<SEC-DOCUMENT>0001193125-21-010290.txt : 20210119
<SEC-HEADER>0001193125-21-010290.hdr.sgml : 20210119
<ACCEPTANCE-DATETIME>20210115184223
ACCESSION NUMBER:		0001193125-21-010290
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20210119
DATE AS OF CHANGE:		20210115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Village Farms International, Inc.
		CENTRAL INDEX KEY:			0001584549
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - CROPS [0100]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-237792
		FILM NUMBER:		21533356

	BUSINESS ADDRESS:	
		STREET 1:		4700 - 80TH STREET
		CITY:			DELTA, BRITISH COLUMBIA
		STATE:			Z4
		ZIP:			V4K 3N3
		BUSINESS PHONE:		732-676-3008

	MAIL ADDRESS:	
		STREET 1:		4700 - 80TH STREET
		CITY:			DELTA, BRITISH COLUMBIA
		STATE:			Z4
		ZIP:			V4K 3N3
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>d88408d424b2.htm
<DESCRIPTION>FORM 424(B)(2)
<TEXT>
<HTML><HEAD>
<TITLE>Form 424(b)(2)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(2)<BR>Registration No. 333-237792 </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>Prospectus Supplement </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>(to prospectus dated
April&nbsp;22, 2020) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman"><B>10,887,097 Common Shares </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g88408g01a88.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">We are offering 10,887,097 common shares (the &#147;<B>Common Shares</B>&#148;) at a public offering price of $12.40 per Common Share in the capital stock of
Village Farms International, Inc. (the &#147;<B>Company</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">We have retained A.G.P./Alliance Global Partners and Raymond James (USA) Ltd., each to
act as exclusive <FONT STYLE="white-space:nowrap">co-lead</FONT> placement agents, and Roth Capital Partners, LLC, as <FONT STYLE="white-space:nowrap">co-placement</FONT> agent (collectively, the &#147;<B>Placement Agents</B>&#148;) in connection
with this offering. The Placement Agents have agreed to use their reasonable best efforts to sell the securities offered by this prospectus supplement and the accompanying prospectus. The Placement Agents are not purchasing or selling any securities
offered by this prospectus supplement and the accompanying prospectus. See &#147;Plan of Distribution&#148; beginning on page <FONT STYLE="white-space:nowrap">S-15</FONT> of this prospectus supplement for more information regarding these
arrangements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">The outstanding Common Shares are listed for trading on the Nasdaq Capital Market (&#147;<B>Nasdaq</B>&#148;) and the Toronto Stock Exchange
(the &#147;<B>TSX</B>&#148;) under the symbol &#147;VFF&#148;. On January&nbsp;14, 2021, the last reported sale price of our Common Shares on Nasdaq and the TSX was US$14.35 and C$18.12, respectively, per share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">The Company has applied to have the Common Shares being offered and sold pursuant to this prospectus supplement listed on the TSX. Listing is subject to the
approval of the TSX in accordance with its applicable listing requirements. The Company has provided notice of this offering to Nasdaq in accordance with the rules of that exchange. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investing in our securities involves a high degree of risk, including that the trading price of our Common Shares has been subject to volatility and
investors in this offering may not be able to sell their Common Shares above the actual offering price or at all. Before making an investment decision, please read the information under the heading &#147;<U><A HREF="#supptoc88408_5">Risk
Factors</A></U>&#148; beginning on page <FONT STYLE="white-space:nowrap">S-4</FONT> of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NEITHER THE SECURITIES AND EXCHANGE COMMISSION (THE &#147;SEC&#148;) NOR ANY STATE OR CANADIAN SECURITIES REGULATOR HAS APPROVED OR DISAPPROVED OF THE
SECURITIES OFFERED HEREBY, PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS SUPPLEMENT OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENCE. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Common&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">135,000,002.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Placement agents&#146; fee<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,425,000.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Proceeds to us, before expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">127,575,002.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">We have agreed to pay the Placement Agents an aggregate cash placement fee equal to 5.5% of the gross proceeds
in this offering. See &#147;Plan of Distribution&#148; beginning on page <FONT STYLE="white-space:nowrap">S-15</FONT> of this prospectus supplement for additional information regarding the compensation payable to the Placement Agents.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Delivery of the securities offered hereby is expected to be made on or about January&nbsp;20, 2021, subject to the satisfaction of
certain closing conditions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><I><FONT STYLE="white-space:nowrap">Co-Lead</FONT> Placement Agents </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:15pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:15pt">
<TD VALIGN="top" ALIGN="center"><B>A.G.P.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Raymond James</B></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><I><FONT STYLE="white-space:nowrap">Co-Placement</FONT> Agent </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Roth Capital Partners </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement dated January&nbsp;15, 2021. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Prospectus Supplement</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-i</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_2">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-iii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_3">PROSPECTUS SUPPLEMENT SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_4">THE OFFERING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_7">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_8">CERTAIN UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_9">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_10">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_11">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_12">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc88408_13">INCORPORATION OF INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Prospectus</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_1">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_2">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">iv</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_3">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_5">ENFORCEABILITY OF CIVIL LIABILITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_7">DESCRIPTION OF COMMON SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_8">DESCRIPTION OF PREFERRED SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_9">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_10">DESCRIPTION OF SUBSCRIPTION RECEIPTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_11">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_12">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_13">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_14">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_15">MATERIAL INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_16">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_17">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_18">WHERE YOU CAN FIND ADDITIONAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_19">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Advisory </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is in two
parts. The first part is this prospectus supplement, which describes the specific terms of this offering and also adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference herein and
therein. The second part, the accompanying prospectus, provides more general information, some of which may not apply to this offering. Generally, when we refer to this prospectus, we are referring to this prospectus supplement and the accompanying
prospectus combined. To the extent there is a conflict between the information contained in this prospectus supplement and the information contained in the accompanying prospectus or any document incorporated by reference herein or therein filed
prior to the date of this prospectus supplement, you should rely on the information in this prospectus supplement; provided that if any statement in one of these documents is inconsistent with a statement in another document having a later
date&#151;for example, a document incorporated by reference in the accompanying prospectus&#151;the statement in the document having the later date modifies or supersedes the earlier statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document
that is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a
representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date specified in the relevant agreement. Accordingly, such representations, warranties and covenants should not be
relied on as accurately representing the current state of our affairs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in or
incorporated by reference in this prospectus supplement, the accompanying prospectus and in any free writing prospectus that we have authorized for use in connection with this offering. We have not, and the Placement Agents have not, authorized
anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the Placement Agents are not, making an offer to sell these securities in any
jurisdiction where the offer or sale is not permitted. You should assume that the information in this prospectus supplement, the accompanying prospectus, the documents incorporated by reference herein and therein, and in any free writing prospectus
that we have authorized for use in connection with this offering, is accurate only as of the date of those respective documents. Our business, financial condition, results of operations and prospects may have changed since those dates. You should
read this prospectus supplement, the accompanying prospectus, the documents incorporated by reference herein and therein, and any free writing prospectus that we have authorized for use in connection with this offering, in their entirety before
making an investment decision. You should also read and consider the additional information in the documents to which we have referred you in the sections of this prospectus supplement and in the accompanying prospectus entitled &#147;Where You Can
Find More Information&#148; and &#147;Incorporation of Information by Reference.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the Placement Agents are offering to sell,
and seeking offers to buy, securities only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement and the accompanying prospectus and the offering of securities in certain jurisdictions may be
restricted by law. Persons outside the United States who come into possession of this prospectus supplement and the accompanying prospectus must inform themselves about, and observe any restrictions relating to, the offering of securities and the
distribution of this prospectus supplement and the accompanying prospectus outside the United States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an offer to sell, or a
solicitation of an offer to buy, any securities offered by this prospectus supplement and the accompanying prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus contains references to our trademarks and to trademarks belonging to other
entities. Solely for convenience, trademarks and trade names referred to in this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prospectus supplement and the accompanying prospectus, including logos, artwork and other visual displays, may appear without the <SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> or TM
symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies&#146; trade
names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interpretation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise noted or the context otherwise requires, the term &#147;cannabis&#148; has the meaning given thereto under the <I>Cannabis Act
</I>(Canada). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this prospectus supplement, the terms &#147;Village Farms,&#148; &#147;Village Farms International,&#148; the
&#147;Company,&#148; &#147;we,&#148; &#147;us,&#148; &#147;our&#148; and similar references refer to Village Farms International, Inc. Our financial information is presented in U.S. dollars and all references in this prospectus supplement to
&#147;$&#148; means U.S. dollars and all references to &#147;C$&#148; means Canadian dollars. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market and Industry Data </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, information contained in this prospectus supplement, the accompanying prospectus or in documents incorporated by
reference the prospectus supplement or the accompany prospectus concerning the Company&#146;s industry and the markets in which it operates or seeks to operate is based on information from third party sources, industry reports and publications,
websites and other publicly available information, and management studies and estimates. Unless otherwise indicated, the Company&#146;s estimates are derived from publicly available information released by third party sources as well as data from
the Company&#146;s own internal research, and include assumptions which the Company believes to be reasonable based on management&#146;s knowledge of the Company&#146;s industry and markets. The Company&#146;s internal research and assumptions have
not been verified by any independent source, and the Company has not independently verified any third-party information. While the Company believes that such third-party information to be generally reliable, such information and estimates are
inherently imprecise. In addition, projections, assumptions and estimates of the Company&#146;s future performance or the future performance of the industry and markets in which the Company operates are necessarily subject to a high degree of
uncertainty and risk due to a variety of factors, including those described in this prospectus supplement and in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> under &#147;Risk Factors&#148;. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Presentation of Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of the Company incorporated by reference in this prospectus supplement are presented in United States dollars and have
been prepared in accordance with United States generally accepted accounting principles (&#147;<B>US GAAP</B>&#148;). Certain calculations included in tables and other figures in this prospectus supplement have been rounded for clarity of
presentation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_2"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform
Act of 1995, Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;) and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), and is subject to the safe
harbor created by those sections. This prospectus supplement also contains &#147;forward-looking information&#148; within the meaning of applicable Canadian securities law. We refer to such forward-looking statements and forward-looking information
collectively as &#147;forward-looking statements&#148;. Forward-looking statements may relate to the Company&#146;s future outlook or financial position and anticipated events or results and may include statements regarding the financial position,
business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results,
performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as
&#147;outlook&#148;, &#147;may&#148;, &#147;might&#148;, &#147;will&#148;, &#147;could&#148;, &#147;should&#148;, &#147;would&#148;, &#147;occur&#148;, &#147;expect&#148;, &#147;plan&#148;, &#147;anticipate&#148;, &#147;believe&#148;,
&#147;intend&#148;, &#147;try&#148;, &#147;estimate&#148;, &#147;predict&#148;, &#147;potential&#148;, &#147;continue&#148;, &#147;likely&#148;, &#147;schedule&#148;, &#147;objectives&#148;, or the negative or grammatical variation thereof or other
similar expressions concerning matters that are not historical facts. The forward-looking statements in this prospectus supplement are subject to risks that may include, but are not limited to: our expectations regarding the completion of this
offering; our limited operating history, including that of Pure Sunfarms Corp. (&#147;<B>Pure Sunfarms</B>&#148;) and our <FONT STYLE="white-space:nowrap">start-up</FONT> operations of growing hemp in the United States; the legal status of Pure
Sunfarms&#146; cannabis business; risks relating to obtaining additional financing, including our dependence upon credit facilities; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent
in the cannabis, hemp and agricultural businesses; the ability of Pure Sunfarms to cultivate and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and licenses (<I>e.g.</I>,
Pure Sunfarms&#146; ability to obtain licenses for its Delta 2 greenhouse facility as well as additional licenses under the Canadian act respecting cannabis to amend to the Controlled Drugs and Substances Act, the Criminal Code and other Acts, S.C.
2018, c. 16 (Canada) for its Delta 3 greenhouse facility), and changes in our regulatory requirements; risks relating to conversion of our greenhouses to cannabis production; risks related to rules and regulations at the U.S. federal (Food and Drug
Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and
other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border
trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; the ongoing and developing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; and tax risks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes
may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this prospectus supplement are based upon assumptions that management believes are reasonable
based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties,
many of which are beyond the Company&#146;s control, that may cause the Company&#146;s or the industry&#146;s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or
implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company&#146;s filings with securities regulators, including this prospectus supplement. In particular, we caution
you that our forward-looking statements are subject to the ongoing and developing circumstances related to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, which may have a material adverse effect on our business, operations and future
financial results. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When relying on forward-looking statements to make decisions, the Company cautions readers
not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The
forward-looking statements made in this prospectus supplement relate only to events or information as of the date on which the statements are made in this prospectus supplement. Except as required by law, the Company undertakes no obligation to
update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_3"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights certain information about us, this offering and selected information contained elsewhere in or incorporated by
reference in this prospectus supplement. This summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in our securities. For a more complete understanding of our company and this
offering, we encourage you to read and consider carefully the more detailed information in this prospectus supplement and the accompanying prospectus, including the information included under the heading &#147;Risk Factors&#148; in this prospectus
supplement beginning on page <FONT STYLE="white-space:nowrap">S-4,</FONT> the information included under the heading &#147;Risk Factors&#148; in the accompanying prospectus beginning on page 1, the information incorporated by reference in this
prospectus supplement and the accompanying prospectus, which is described under &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Information by Reference,&#148; and the information included in any free writing prospectus
that we have authorized for use in connection with this offering. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is a corporation incorporated under the Canada Business Corporations Act. The head and registered office of the Company and each of
its Canadian subsidiaries is located at 4700-80th Street, Delta, British Columbia, Canada, V4K 3N3 and its telephone number is <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">604-940-6012.</FONT></FONT> Through our wholly-owned
subsidiary, Pure Sunfarms, we have one of the single largest cannabis growing operations in the world. We are also one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded
greenhouse produce company in Canada. Further, we have joint venture operations in hemp and high cannabidiol (&#147;<B>CBD</B>&#148;) products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We leverage 30 years of experience as a vertically integrated greenhouse grower for the rapidly emerging cannabis opportunity following
legalization of cannabis in Canada. We are currently one of the largest producers of cannabis in Canada with distribution in five of the provinces. Our long-term objective is to be the leading low cost, high quality cannabis producer in Canada. In
our greenhouse operations, we produce and distribute fresh, premium-quality produce with consistency 365 days a year to national grocers in the U.S. and Canada from more than eight million square feet of Controlled Environment Agriculture
greenhouses in British Columbia and Texas, as well as from our partner greenhouses in British Columbia, Ontario and Mexico. We are also pursuing opportunities to become a vertically integrated leader in the U.S. hemp-derived CBD market, subject to
compliance with all applicable U.S. federal and state laws. We have established two joint ventures, Village Fields Hemp USA, LLC, and Arkansas Valley Green and Gold Hemp LLC, for multi-state outdoor hemp cultivation and CBD extraction and plans to
pursue controlled environment hemp production at our Texas greenhouse operations, which total 5.7&nbsp;million square feet of production area, subject to legalization of hemp in Texas. Our subsidiary, VF Clean Energy, Inc., owns and operates a 7.0
MW power plant that generates electricity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further information regarding the Company and its business is set out in our Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K,</FONT> which is incorporated herein by reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Factors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our Common Shares involves a high degree of risk. You should carefully consider the risks described in &#147;Risk Factors&#148;
beginning on page <FONT STYLE="white-space:nowrap">S-4</FONT> of this prospectus supplement before making a decision to invest in our Common Shares. If any of these risks actually occurs, our business, financial condition and results of operations
would likely be materially adversely affected. In such case, the trading price of our Common Shares would likely decline and you may lose part or all of your investment. Below is a summary of the principal risks we face: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our limited operating history, including that of Pure Sunfarms and our
<FONT STYLE="white-space:nowrap">start-up</FONT> operations of growing hemp in the United States; </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the legal status of Pure Sunfarms cannabis business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to obtaining additional financing, including our dependence upon credit facilities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential difficulties in achieving and/or maintaining profitability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variability of product pricing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks inherent in the cannabis, hemp and agricultural businesses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of Pure Sunfarms to cultivate and distribute cannabis in Canada; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">existing and new governmental regulations, including risks related to regulatory compliance and licenses (e.g.,
Pure Sunfarms&#146; ability to obtain licenses for its Delta 2 greenhouse facility as well as additional licenses under the Canadian act respecting cannabis to amend to the Controlled Drugs and Substances Act, the Criminal Code and other Acts, S.C.
2018, c. 16 (Canada) for its Delta 3 greenhouse facility), and changes in our regulatory requirements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to conversion of our greenhouses to cannabis production for Pure Sunfarms; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks related to rules and regulations at the U.S. federal (Food and Drug Administration and United States
Department of Agriculture), state and municipal levels with respect to produce and hemp; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">retail consolidation, technological advances and other forms of competition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transportation disruptions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product liability and other potential litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties in managing our growth; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictive covenants under our credit facilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ongoing and developing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">tax risks. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_4"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common Shares offered by us </P></TD>
<TD>We are offering 10,887,097 Common Shares at a public offering price of $12.40 per Common Share. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common Shares outstanding immediately before this offering </P></TD>
<TD>66,931,811 Common Shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common Shares to be outstanding immediately after this offering </P></TD>
<TD>77,818,908 Common Shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of Proceeds </P></TD>
<TD>We estimate that our net proceeds from this offering will be approximately $127.18&nbsp;million, after deducting placement agent fees and estimated offering expenses payable by us. We intend to use the net proceeds from this offering for general
working capital. See &#147;Use of Proceeds.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk Factors </P></TD>
<TD>An investment in our securities involves a high degree of risk. See &#147;Risk Factors&#148; beginning on page <FONT STYLE="white-space:nowrap">S-4</FONT> for a discussion of some of the factors you should carefully consider before deciding to
invest in our securities. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Nasdaq Capital Market and TSX symbol for the Common Shares </P></TD>
<TD>Our Common Shares currently trade on Nasdaq and the TSX under the symbol &#147;VFF.&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of Common Shares
to be outstanding immediately after this offering is based on 66,931,811 Common Shares outstanding as of January&nbsp;14, 2021 and excludes, as of that date, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,047,322 Common Shares issuable upon exercise of outstanding options at a weighted-average exercise price of
C$5.46 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">869,000 Common Shares issuable upon achievement of employment-related performance goals; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2,776,859 Common Shares reserved and available for issuance upon exercise of additional options that may be
granted in the future under our equity compensation plans; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,698,113 Common Shares issuable upon exercise of outstanding warrants at an exercise price of $5.80 per share.
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>An investment in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider
carefully the risks described below and discussed under the sections captioned &#147;Risk Factors&#148; contained in our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended September&nbsp;30, 2020 and our
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2019, as amended, each of which is incorporated by reference in this prospectus supplement and the accompanying prospectus, together with other
information in this prospectus supplement, the accompanying prospectus, the information and documents incorporated by reference, and in any free writing prospectus that we have authorized for use in connection with this offering. See &#147;Where You
Can Find More Information&#148; and &#147;Incorporation of Certain Information by Reference&#148;. If any of these or other risks occur, the Company&#146;s business, prospects, financial condition, results of operations and cash flows could be
materially and adversely impacted. In that case, the trading price of the Common Shares could decline and investors could lose all or part of their investment in the Common Shares. There is no assurance that any risk management steps taken will
avoid future loss due to the occurrence of the below described risks or other unforeseen risks. Additional risks and uncertainties not currently known to the Company, or that are currently deemed immaterial, may also materially and adversely affect
the Company&#146;s business prospects, financial condition, results of operations and/or cash flows. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to This Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>This is a best efforts offering, no minimum amount of securities is required to be sold, and we may not raise the amount of capital we
believe is required for our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Placement Agents have agreed to use their reasonable best efforts to solicit offers to
purchase the securities in this offering. The Placement Agents have no obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar amount of the securities. There is no required minimum
number of securities that must be sold as a condition to completion of this offering. Because there is no minimum offering amount required as a condition to the closing of this offering, the actual offering amount, placement agent fees and proceeds
to us are not presently determinable and may be substantially less than the maximum amounts set forth above. We may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and
investors in this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to pursue the business goals outlined in this prospectus. Thus, we may not raise the amount of capital we believe is required
for our business and may need to raise additional funds, which may not be available or available on terms acceptable to us. Despite this, any proceeds from the sale of securities offered by us will be available for our immediate use, and because
there is no escrow account and no minimum offering amount in this offering, investors could be in a position where they have invested in us, but we are unable to fulfill our objectives due to a lack of interest in this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>An investment in the Common Shares is extremely speculative and there can be no assurance of any return on any such investment.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in the Common Shares is extremely speculative and there is no assurance that investors will obtain any return on
their investment. Investors will be subject to substantial risks involved in an investment in us, including the risk of losing their entire investment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>We have broad discretion in the use of the net proceeds we receive from this offering and may not use them effectively. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management will have broad discretion in the application of the net proceeds we receive in this offering, including for the purposes
described in the section entitled &#147;Use of Proceeds,&#148; and you will not have the opportunity as part of your investment decision to assess whether our management is using the net proceeds appropriately. Because of the number and variability
of factors that will determine our use of our net proceeds </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
from this offering, their ultimate use may vary substantially from their currently intended use. The failure by our management to apply these funds effectively could result in financial losses
that could have a material adverse effect on our business and cause the price of our Common Shares to decline. Pending their use, we may invest our net proceeds from this offering in short-term, investment-grade, interest-bearing securities. These
investments may not yield a favorable return to our shareholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Potential volatility of the price of our Common Shares.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price for our Common Shares may be volatile and subject to wide fluctuations in response to numerous factors, many of
which are beyond the Company&#146;s control, including the following: (i)&nbsp;actual or anticipated fluctuations in the Company&#146;s quarterly results of operations; (ii)&nbsp;recommendations by securities research analysts; (iii)&nbsp;changes in
the economic performance or market valuations of other issuers that investors deem comparable to the Company; (iv)&nbsp;addition or departure of the Company&#146;s executive officers and other key personnel; (v)&nbsp;release or expiration of <FONT
STYLE="white-space:nowrap">lock-up</FONT> or other transfer restrictions on outstanding Common Shares; (vi)&nbsp;sales or perceived sales of additional Common Shares; (vii)&nbsp;significant acquisitions or business combinations, strategic
partnerships, joint ventures or capital commitments by or involving the Company or its competitors; and (viii)&nbsp;news reports relating to trends, concerns, technological or competitive developments, regulatory changes and other related issues in
the Company&#146;s industries or target markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial markets have recently experienced significant price and volume fluctuations
that have particularly affected the market prices of equity securities of public entities and that have, in many cases, been unrelated to the operating performance, underlying asset values or prospects of such entities. Accordingly, the market price
of the Common Shares may decline even if the Company&#146;s operating results, underlying asset values or prospects have not changed. Additionally, these factors, as well as other related factors, may cause decreases in asset values that are deemed
to be other than temporary, which may result in impairment losses. As well, certain institutional investors may base their investment decisions on consideration of the Company&#146;s environmental, governance and social practices and performance
against such institutions&#146; respective investment guidelines and criteria, and failure to satisfy such criteria may result in limited or no investment in the Common Shares by those institutions, which could materially adversely affect the
trading price of the Common Shares. There can be no assurance that continuing fluctuations in price and volume will not occur. If such increased levels of volatility and market turmoil continue for a protracted period of time, the Company&#146;s
operations and the trading price of the Common Shares may be materially adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Future sales and issuances of our
Common Shares or rights to purchase our Common Shares could result in substantial dilution to the percentage ownership of our shareholders. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of Common Shares that the Company is authorized to issue is unlimited. We expect that significant additional capital will be needed
in the future to continue our planned operations. To raise capital, we may sell Common Shares or other securities convertible into or exchanged for our Common Shares in one or more transactions, and in a manner we determine from time to time and at
prices that may not be the same as the price per share paid by other investors, and dilution to our shareholders could result. To the extent that any of the net proceeds of this offering remain <FONT STYLE="white-space:nowrap">un-invested</FONT>
pending their use, or are used to pay down existing indebtedness with a low interest rate, this offering may result in substantial dilution on a per share basis to the Company&#146;s net income and certain other financial measures used by the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as of January&nbsp;14, 2021, there were 3,047,322 Common Shares issuable upon exercise of outstanding options at a
weighted-average exercise price of C$5.46 per share; 869,000 Common Shares issuable upon achievement of employment-related performance goals; 2,776,859 Common Shares reserved and available for issuance upon exercise of additional options that may be
granted in the future under our equity compensation plans; and 4,698,113 Common Shares issuable upon exercise of outstanding warrants at an exercise price of $5.80 per share. These additional issuances could result in substantial dilution to the
percentage ownership of our shareholders, including the investors in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Risks Related to the Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>There can be no assurance that current and future mergers, acquisitions, divestitures, alliances, joint ventures, investments or other
strategic transactions will be consummated or have a positive impact on our business, prospects, financial condition, or results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Historically, the senior management of the Company and the Company&#146;s board have been engaged in discussions surrounding the strategic
direction of the Company in light of, among other things, the rapid growth and substantial changes in the cannabis industry and the other businesses in which we operate. As part of these discussions, senior management of the Company and the
Company&#146;s board from time to time have considered, and may consider in the future, various transactions in the context of its long-term business plan, including mergers, acquisitions, divestitures, alliances, joint ventures, investments or
other strategic transactions. The Company also has also been approached from time to time by parties wishing to discuss potential commercial or acquisition opportunities. In certain cases, the Company has entered into confidentiality agreements with
third parties under which the Company provided certain <FONT STYLE="white-space:nowrap">non-public</FONT> information to those parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company can give no assurance that any such discussions will result in a transaction or that any such transaction ultimately will have a
positive impact on our business, prospects, financial condition, or results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Global Coronavirus Pandemic </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, a novel strain of coronavirus, <FONT STYLE="white-space:nowrap">COVID-19,</FONT> was reported to have surfaced in Wuhan,
China. On March&nbsp;11, 2020, the World Health Organization declared this outbreak a global pandemic. Major health issues and pandemics, such as the coronavirus, may adversely affect trade, global and local economies and the trading prices of the
Common Shares. Given the ongoing and dynamic nature of the circumstances, the extent to which the coronavirus will impact the Company&#146;s financial results and operations is uncertain. The Company&#146;s cannabis operations and financial
performance (including with respect to Pure Sunfarms) were negatively impacted by COVID-19 in 2020 and may be materially adversely affected by COVID-19 in 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tax Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company were classified
as a passive foreign investment company (&#147;<B>PFIC</B>&#148;) for U.S. federal income tax purposes, certain generally adverse U.S. federal income tax consequences could apply to U.S. investors. The Company generally will be classified as a PFIC
for any taxable year in which its passive income or its assets that produce passive income exceed certain thresholds. If the Company were a PFIC for any year during the holding period of a U.S. Holder (as defined below) of Common Shares, then such
holder generally would be required to treat any gain realized upon a disposition of Common Shares, or any &#147;excess distribution&#148; received on its Common Shares, as ordinary income, and to pay an interest charge on a portion of such gain or
distribution, unless the holder were to make certain elections, to the extent available, in a timely and effective manner. The Company has not determined whether it will be a PFIC for the year in which this offering is completed or in future years
because, among other things, PFIC status is determined annually and is based on a corporation&#146;s income, assets, and activities for the entire taxable year. Moreover, the determination as to whether any corporation was, or will be, a PFIC for a
particular taxable year depends, in part, on the application of complex U.S. federal income tax rules, which are subject to differing interpretations and uncertainty. Accordingly, there can be no assurance that the Company is not currently or will
not be classified as a PFIC for any taxable year. This paragraph is qualified in its entirety by the discussion below under the heading &#147;Certain United States Federal Income Tax Considerations&#151;Passive Foreign Investment Company
Considerations.&#148; Each U.S. Holder is urged to consult its own tax adviser regarding the PFIC status of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that the net proceeds of this offering will be approximately $127.18&nbsp;million after deducting placement agent fees and estimated
offering expenses payable by us. The Company intends to use the net proceeds of this offering for general working capital. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_7"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Common Shares are registered under Section&nbsp;12 of the Exchange Act and are traded on Nasdaq and the TSX under the symbol
&#147;VFF&#148;. No other securities of the Company are registered under Section&nbsp;12 of the Exchange Act. The following description of our Common Shares is a summary of the material terms of such securities. For more information, we refer you to
our Articles of Amalgamation, <FONT STYLE="white-space:nowrap">By-laws</FONT> and <FONT STYLE="white-space:nowrap">By-laws</FONT> amendment, copies of which are filed as exhibits to our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized Capital Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue an unlimited number of Common Shares, no par value, an unlimited number of preferred shares
(&#147;<B>Preferred Shares</B>&#148;) and an unlimited number of special voting shares (&#147;<B>Special Shares</B>&#148;) of the Company. As of January&nbsp;14, 2021, the Company had 66,931,811 Common Shares, no Preferred Shares and no Special
Shares issued and outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Common Share entitles the holder thereof to receive notice of and to attend all meetings of shareholders of the Company and to one vote
per Common Share at such meetings (other than meetings at which only the holders of another class of shares are entitled to vote separately as a class). The Common Shares entitle the holders thereof to receive, in any year, dividends on the Common
Shares as and when declared by the board of directors of the Company, provided that payment of such dividends is not prohibited under law and after payment of any applicable amounts to which holders of any Preferred Shares may be entitled. In the
event of the liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of the Company, whether voluntary or involuntary, after payment of or other proper provision for all of the liabilities of the Company and the payment of any
amounts payable to holders of the Preferred Shares, the holders of the Common Shares will be entitled to share <I>pro rata </I>in all remaining property or assets of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ability of a beneficial owner of Common Shares to pledge such Common Shares or otherwise take action with respect to such
shareholder&#146;s interest in such Common Shares (other than through a participant in the depository service provided by CDS Clearing and Depository Services Inc. or The Depository Trust Company) may be limited due to the lack of a physical Common
Share certificate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue an unlimited number of Preferred Shares. The Company&#146;s board of directors will fix the number of
Preferred Shares, as well as the designation, rights, privileges, restrictions and conditions for each series of Preferred Shares that may be issued, subject to the Company filing the applicable articles of amendment under the Canada Business
Corporations Act. Preferred Shares will have preference over Common Shares with respect to the payment of dividends and in the distribution of assets in the event of the liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT>
of the Company, be it voluntary or involuntary, or any other distribution of the assets of the Company among its shareholders for the purpose of <FONT STYLE="white-space:nowrap">winding-up</FONT> its affairs. Preferred Shares will have no right to
vote on shareholder matters, subject to certain exceptions. No changes to the provisions of the Preferred Shares may be made without the approval of the holders of the Preferred Shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Special Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are authorized to
issue an unlimited number of Special Shares and the holders of such Special Shares will be entitled to one vote per Special Shares held at all meetings of shareholders of the Company. However, in no event shall the votes attached to the Special
Shares exceed 45% of the votes otherwise attached to the Common Shares and the Special Shares then outstanding. The authorization of Special Shares will make it </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
possible for us to issue shares with voting or other rights or preferences that could have an effect of delaying, deferring or preventing a change in control of the Company. The authorization of
Special Shares is a historical framework that was carried over from the capital structure of Village Farms Income Fund, the Company&#146;s predecessor. No Special Shares are issued or outstanding and the Company does not intend to issue Special
Shares in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Retained Interest of Michael DeGiglio </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Amended and Restated Securityholders&#146; Agreement, by, among others, the Company and Michael DeGiglio, dated
December&nbsp;31, 2009 (the &#147;<B>Securityholders&#146; Agreement</B>&#148;), the Company has granted to its Chief Executive Officer, Michael DeGiglio, certain <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, as well as
&#147;demand&#148; and &#147;piggy back&#148; registration rights. These rights enable Mr.&nbsp;DeGiglio to require the Company to file a prospectus (in the case of a demand registration) and otherwise assist with a public offering of Common Shares,
subject to certain limitations. In the event of a &#147;piggy back&#148; offering, the Company&#146;s financing requirements are to take priority. Subject to the approval of the TSX, in the event that the Company decides to issue equity securities
or securities convertible into or exchangeable for equity securities of the Company other than to officers, employees, consultants or directors of the Company or any subsidiary of the Company pursuant to a <I>bona fide </I>incentive compensation
plan, the Securityholders&#146; Agreement provides, among other things, Mr.&nbsp;DeGiglio with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights to purchase such number of newly issued equity securities in order to maintain his <I>pro rata
</I>ownership interest in the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;DeGiglio has agreed to waive such rights under the Securityholders&#146; Agreement in
connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our Common Shares is Computershare Investor Services Inc. at its principal offices in Vancouver, British
Columbia or Toronto, Ontario, with Continental Stock Transfer&nbsp;&amp; Trust Company, at its principal offices in New York, New York, the U.S. agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_8"></A>CERTAIN UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of certain U.S. federal income tax considerations generally applicable to a U.S. Holder (as defined below)
of the ownership and disposition of Common Shares acquired pursuant to this Offering. This summary is based on provisions of the Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;), on the Treasury Regulations promulgated
thereunder, and on published administrative rulings, judicial decisions, and other applicable authority, all as in effect on the date hereof and all of which are subject to change at any time, possibly with retroactive effect. The summary addresses
only U.S. Holders that acquire and hold Common Shares as &#147;capital assets&#148; within the meaning of the Code (generally, property held for investment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary is necessarily general and may not apply to all categories of holders, some of whom may be subject to special rules, including,
without limitation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that own (directly, indirectly, or constructively, applying certain attribution rules) 10% or more of the
total voting power or total value of the stock of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">dealers in securities or currencies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">financial institutions or financial services entities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">mutual funds; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">life insurance companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that hold Common Shares as part of a straddle, hedging transaction, conversion transaction, constructive
sale or other arrangement involving more than one position; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that acquired Common Shares in connection with the exercise of employee stock options or otherwise as
compensation for services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons whose functional currency is not the U.S. dollar; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who have elected
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> accounting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold Common Shares through a partnership or other entity treated as a pass-through entity for U.S.
federal income tax purposes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons subject to the alternative minimum tax or the unearned income Medicare contribution tax on net investment
income; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain U.S. expatriates or former long-term residents of the United States. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary does not address all potentially relevant U.S. federal income tax matters, nor does it address any state, local, foreign, estate,
or gift tax consequences of holding or disposing of Common Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used herein, the term &#147;<B>U.S. Holder</B>&#148; means any
beneficial owner of Common Shares who, for U.S. federal income tax purposes, is: (i)&nbsp;a citizen or individual resident of the United States; (ii)&nbsp;a corporation (or other entity classified as a corporation for U.S. federal tax purposes)
organized under the laws of the United States or of any state thereof or the District of Columbia, (iii)&nbsp;an estate whose income is subject to U.S. federal income taxation regardless of its source, and (iv)&nbsp;a trust (A)&nbsp;if a U.S. court
is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (B)&nbsp;that has elected to be treated as a U.S. person under
applicable Treasury Regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a partnership (or other entity or arrangement treated as a partnership for U.S. federal tax purposes)
holds Common Shares, the tax treatment of a partner generally will depend upon the status of the partner and the activities of the partnership. Partnerships (or other entities or arrangements classified as a partnership for U.S. federal tax
purposes) holding Common Shares, and their partners and other owners, are urged to consult their own tax advisers to determine the U.S. federal, state, local, and other tax consequences that may be relevant to them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Prospective investors are urged to consult their own tax advisers with respect to the
tax considerations relevant to the ownership and disposition of the Common Shares acquired pursuant to this Offering, having regard to their particular circumstances. </I></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ownership and Disposition of the Common Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Taxation of Distributions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company has not paid any cash dividends to date and does not intend to declare dividends for the foreseeable future. In the event that the Company pays a dividend, and subject to the discussion below under &#147;Passive Foreign Investment Company
Considerations,&#148; a U.S. Holder generally will recognize, to the extent out of the Company&#146;s current and accumulated earnings and profits (as determined in accordance with U.S. federal income tax principles), dividend income on the receipt
of distributions on Common Shares (including amounts withheld to pay any Canadian withholding taxes). To the extent that the amount of a distribution exceeds the Company&#146;s current and accumulated earnings and profits, it will be treated first
as a <FONT STYLE="white-space:nowrap">tax-free</FONT> return of a U.S. Holder&#146;s tax basis in its Common Shares, and to the extent the amount of the distribution exceeds such U.S. Holder&#146;s tax basis, the excess will be taxed as capital
gain. The Company does not intend to calculate its earnings and profits according to U.S. federal income tax principles. Accordingly, U.S. Holders should expect a distribution generally to be treated as a dividend for U.S. federal income tax
purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends received by individuals and other <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. Holders of Common Shares
traded on the Nasdaq generally will be subject to tax at preferential rates applicable to long-term capital gains, provided that such holders meet certain holding period and other requirements and that the Company is not treated as a PFIC for the
taxable year in which the dividend is paid or for the preceding taxable year. Dividends on Common Shares generally will not be eligible for the dividends-received deduction allowed to corporations. Dividends paid by the Company generally will
constitute foreign-source income for foreign tax credit limitation purposes. A U.S. Holder may be entitled to deduct or credit any Canadian withholding taxes on dividends in determining its U.S. income tax liability, subject to certain limitations
(including that the election to deduct or credit foreign taxes applies to all of such U.S. Holder&#146;s foreign taxes for a particular tax year). The limitation on foreign taxes eligible for credit is calculated separately with respect to specific
classes of income. Dividends distributed by the Company with respect to Common Shares generally will constitute &#147;passive category&#148; income. The rules governing the foreign tax credit are complex. Each U.S. Holder is urged to consult its own
tax adviser regarding the availability of the foreign tax credit with respect to such holder&#146;s particular circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount
of any dividend paid to a U.S. Holder in Canadian dollars (including amounts withheld to pay Canadian withholding taxes) will be includible in income in a U.S. dollar value amount by reference to the exchange rate between the U.S. dollar and the
Canadian dollar in effect on the date of receipt of such dividend by the U.S. Holder, regardless of whether the Canadian dollars so received are in fact converted into U.S. dollars. A U.S. Holder will have a tax basis in the Canadian dollars equal
to their U.S. dollar value on the date of receipt. If the Canadian dollars received are converted into U.S. dollars on the date of receipt, the U.S. Holder generally should not be required to recognize foreign currency gain or loss in respect of the
dividend. If the Canadian dollars received are not converted into U.S. dollars on the date of receipt, a U.S. Holder may recognize foreign currency gain or loss on a subsequent conversion or other disposition of the Canadian dollars. Such gain or
loss generally will be treated as U.S.-source ordinary income or loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each U.S. Holder is urged to consult its own tax adviser regarding
the application of the foregoing rules in light of such holder&#146;s particular circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sale, Exchange, or Other Taxable Disposition of the
Common Shares </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#147;Passive Foreign Investment Company Considerations,&#148; upon a sale,
exchange, or other taxable disposition of a Common Share, a U.S. Holder generally will recognize a capital gain </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or loss equal to the difference between the amount realized on such sale, exchange or other taxable disposition (or, if the amount realized is denominated in Canadian dollars, its U.S. dollar
equivalent, generally, for U.S. Holders that use the cash method and for electing U.S. Holders that use the accrual method, determined by reference to the spot rate of exchange on the date of settlement) and the holder&#146;s tax basis of such
Common Share. Such gain or loss will be long-term capital gain or loss if the Common Share has been held for more than one year and will be short-term capital gain or loss if the holding period is equal to or less than one year. Such gain or loss
generally will be considered U.S.-source gain or loss for U.S. foreign tax credit purposes. Long-term capital gains of non-corporate taxpayers are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Passive Foreign Investment Company Considerations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain generally adverse U.S. federal income tax consequences could apply to a U.S. Holder if the Company is treated as a PFIC for any taxable
year during such U.S. Holder&#146;s holding period for the Common Shares, as determined under the PFIC rules. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> corporation, such as the Company, will be classified as a PFIC for U.S. federal income
tax purposes for any taxable year in which either (i) 75% or more of its gross income for such year consists of certain types of &#147;passive&#148; income or (ii) 50% or more of the value of its assets during such year produce or are held for the
production of passive income. Passive income generally includes dividends, interest, royalties, rents, annuities, net gains from the sale or exchange of property producing such income, and net foreign currency gains. For purposes of the income test
and asset test, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> corporation that directly or indirectly owns at least 25% by value of the shares of another corporation is treated as if it held its proportionate share of the assets of the other
corporation and received directly its proportionate share of the income of the other corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under certain attribution rules, if the
Company were a PFIC, U.S. Holders generally would be deemed to own their proportionate share of the Company&#146;s direct or indirect equity interest in any company that is also a PFIC (a &#147;<B>Subsidiary PFIC</B>&#148;) and would be subject to
U.S. federal income tax on any indirect gain realized on the stock of a Subsidiary PFIC upon the sale of the Common Shares of the Company, as well as their proportionate share of (i)&nbsp;any &#147;excess distributions&#148; (as discussed below) on
the stock of a Subsidiary PFIC and (ii)&nbsp;any gain realized upon the disposition or deemed disposition of stock of a Subsidiary PFIC by the Company or by another Subsidiary PFIC, both as if such U.S. Holders directly held the shares of such
Subsidiary PFIC. If the Company were classified as a PFIC for any taxable year in which a U.S. Holder held Common Shares, then the Company generally would continue to be classified as a PFIC with respect to such U.S. Holder for any subsequent
taxable year in which the U.S. Holder continued to hold Common Shares, even if the Company&#146;s income or assets would not cause it to be a PFIC in such subsequent taxable year, unless an exception were to apply. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has not determined whether it will be a PFIC for the year in which this Offering is completed or in future years because, among
other things, PFIC status is determined annually and is based on the Company&#146;s income, assets, and activities for the entire taxable year. Moreover, the determination as to whether any corporation was, or will be, a PFIC for a particular
taxable year depends, in part, on the application of complex U.S. federal income tax rules, which are subject to differing interpretations and uncertainty. Accordingly, there can be no assurance that the Company is not currently or will not be
classified as a PFIC for any taxable year. Each U.S. Holder is urged to consult its own tax adviser regarding the PFIC status of the Company and any Subsidiary PFIC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company were a PFIC for any taxable year during a U.S. Holder&#146;s holding period for Common Shares, and such U.S. Holder had not
made an effective QEF Election or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election under the PFIC rules (as defined and more fully described below) with respect to its Common Shares, then such
holder generally would be subject to special rules with respect to &#147;excess distributions&#148; made by the Company on the Common Shares and with respect to gain from the direct or indirect disposition of Common Shares. An &#147;excess
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
distribution&#148; generally would include the excess of distributions made with respect to the Common Shares to a U.S. Holder in any taxable year over 125% of the average annual distributions
made to such U.S. Holder by the Company during the shorter of the three preceding taxable years or such U.S. Holder&#146;s holding period for the Common Shares. Generally, a U.S. Holder would be required to allocate any excess distribution or gain
from the direct or indirect disposition of the Common Shares ratably over its holding period for the Common Shares. Amounts allocated to the year of the disposition or excess distribution would be taxed as ordinary income, and amounts allocated to
prior taxable years would be taxed at the highest tax rate in effect for ordinary income for each such year. In addition, an interest charge would apply. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company were a PFIC for any taxable year in which a U.S. Holder held Common Shares, and such U.S. Holder had made a timely and
effective election to treat the Company as a &#147;qualified electing fund&#148; (a &#147;<B>QEF Election</B>&#148;) for the first taxable year of such U.S. Holder&#146;s holding period in which the Company were classified as a PFIC, then such U.S.
Holder generally would not be subject to the PFIC rules described in the preceding paragraph. Instead, such U.S. Holder would be subject to U.S. federal income tax on such holder&#146;s pro rata share of (i)&nbsp;the net capital gain of the Company,
which would be taxed as long-term capital gain to such U.S. Holder, and (ii)&nbsp;the ordinary earnings of the Company, which would be taxed as ordinary income to such U.S. Holder. However, a QEF Election cannot be made unless the Company provides
or makes available certain information. The Company does not intend to provide information necessary for U.S. Holders to make QEF Elections, and therefore U.S. Holders should assume that QEF Elections will not be available to them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As an alternative to a QEF Election, if the Company were a PFIC for any taxable year in which a U.S. Holder held Common Shares, and such U.S.
Holder had made a timely and effective &#147;mark to market&#148; election (a &#147;<B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election</B>&#148;) in the first taxable year of such U.S.
Holder&#146;s holding period in which the Company were classified as a PFIC, then such U.S. Holder generally would not be subject to the PFIC rules described in the preceding paragraphs. Instead, such U.S. Holder generally would include in ordinary
income, for each taxable year in which the Company were a PFIC, an amount equal to the excess, if any, of (i)&nbsp;the fair market value of the Common Shares, as of the close of such taxable year over (ii)&nbsp;such U.S. Holder&#146;s adjusted tax
basis in such Common Shares. The U.S. Holder would be entitled to deduct as an ordinary loss each year the excess of its adjusted tax basis in the Common Shares over their fair market value at the end of the year, but only to the extent of the net
amount previously included in income as a result of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election. A U.S. Holder&#146;s adjusted tax basis in the Common Shares would be increased by the
amount of any income inclusion and decreased by the amount of any deductions under the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election rules. In addition, upon a sale or other taxable
disposition of Common Shares, a U.S. Holder that made a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election would recognize ordinary income or ordinary loss (but only to the extent such loss did
not exceed the net amount of previously included income as a result of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election). A
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election would apply to the taxable year in which such election is made and to each subsequent taxable year, unless the Common Shares were to cease to be
&#147;marketable stock,&#148; the U.S. Holder were to mark the Common Shares to market under <FONT STYLE="white-space:nowrap">non-PFIC</FONT> provisions of the Code, or the Internal Revenue Service (&#147;<B>IRS</B>&#148;) were to consent to the
revocation of such election. The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election is expected to be available with respect to the Company, provided that the Common Shares are &#147;regularly
traded&#148; for U.S. federal income tax purposes. The Common Shares will be treated as regularly traded in any calendar year in which more than a de minimis quantity of the Common Shares are traded on a &#147;qualified exchange&#148; on at least 15
days during each calendar quarter. The Nasdaq and TSX, where the Common Shares are expected to be listed, are qualified exchanges for this purpose. However, the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election will not be available with respect to any Subsidiary PFIC. Accordingly, U.S. Holders making a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election would be subject to unfavorable tax consequences described above with respect to any Subsidiary PFIC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In any year in which the Company is classified as a PFIC, a U.S. Holder generally will be required to file an annual report with the IRS
containing certain information regarding such holder&#146;s interest in the Company (or a Subsidiary PFIC), subject to certain exceptions. A failure to satisfy such reporting requirement could result in the extension of the statute of limitations
with respect to federal income tax returns filed by such U.S. Holder. The PFIC rules are complex, and they remain subject to proposed Treasury Regulations that have yet to be made </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
final. Each U.S. Holder should consult its own tax adviser regarding the foregoing reporting requirements, the advisability of making a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Mark-to-Market</FONT></FONT> Election, the impact of the proposed Treasury Regulations, and any other tax consequences under the PFIC rules of acquiring, owning, and disposing of Common Shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Financial Asset Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain U.S. Holders are required to report information relating to an interest in Common Shares, subject to certain exceptions (including an
exception for Common Shares held in accounts maintained by certain financial institutions) by filing IRS Form 8938 (Statement of Specified Foreign Financial Assets) with their U.S. federal income tax returns. Significant penalties may apply for the
failure to satisfy these reporting obligations. Each U.S. Holder is urged to consult its own tax adviser regarding the information reporting obligations, if any, with respect to such holder&#146;s ownership and disposition of Common Shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions on Common Shares made to a U.S. Holder and proceeds from the sale or other disposition of Common Shares may, under certain
circumstances, be subject to information reporting and backup withholding, unless the holder provides proof of an applicable exemption or, in the case of backup withholding, furnishes its taxpayer identification number and otherwise complies with
all applicable requirements of the backup withholding rules. Backup withholding is not an additional tax and generally will be allowed as a refund or credit against the holder&#146;s U.S. federal income tax liability, provided that the required
information is timely furnished to the IRS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THE ABOVE SUMMARY IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OF ALL TAX CONSIDERATIONS
APPLICABLE TO U.S. HOLDERS WITH RESPECT TO THE ACQUISITION, OWNERSHIP, AND DISPOSITION OF COMMON SHARES. U.S. HOLDERS ARE URGED TO CONSULT THEIR OWN TAX ADVISERS AS TO THE TAX CONSIDERATIONS APPLICABLE TO THEM WITH REGARD TO THEIR PARTICULAR
CIRCUMSTANCES. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_9"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A.G.P/Alliance Global Partners and Raymond James (USA) Ltd. have agreed to act as our co-lead placement agents, and Roth Capital Partners,
LLC, has agreed to act as co-placement agent, which we refer to collectively herein as the Placement Agents, in connection with this offering subject to the terms and conditions of the placement agency agreement dated January&nbsp;15, 2021. The
Placement Agents are not purchasing or selling any of the Common Shares offered by this prospectus supplement, nor are they required to arrange the purchase or sale of any specific number or dollar amount of the Common Shares, but have agreed to use
their reasonable best efforts to arrange for the sale of all of the Common Shares offered hereby. Therefore, we will enter into securities purchase agreements directly with investors in connection with this offering and we may not sell the entire
amount of the Common Shares offered pursuant to this prospectus supplement. We will make offers only to a limited number of qualified institutional buyers and institutional accredited investors (within the meaning of U.S. securities laws). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commissions and Expenses </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed
to pay the Placement Agents an aggregate cash placement fee equal to 5.5% of the gross proceeds in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table
provides information regarding the amount of the Placement Agents fees to be paid to the Placement Agents by us, before expenses assuming the purchase of all of the Common Shares offered hereby on a best efforts basis: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Common&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">135,000,002.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Placement Agents&#146; fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,425,000.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">127,575,002.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because there is no minimum offering amount required as a condition to closing in this offering, the actual
total offering commissions, if any, are not presently determinable and may be substantially less than the maximum amount set forth above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beacon Securities Limited has also acted as our financial advisor for this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our obligation to issue and sell Common Shares to the purchasers is subject to the conditions set forth in the securities purchase agreements,
which may be waived by us at our discretion. A purchaser&#146;s obligation to purchase Common Shares is subject to the conditions set forth in his, her or its securities purchase agreement as well, which may also be waived. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently anticipate that the sale of the Common Shares will be completed on or about January 20, 2021. We estimate the total offering
expenses of this offering that will be payable by us, excluding the Placement Agents fees, will be approximately $400,000, which includes legal and printing costs and various other fees. At the closing, The Depository Trust Company will credit the
Common Shares to the respective accounts of the investors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regulation M Restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Placement Agents may be deemed to be underwriters within the meaning of Section&nbsp;2(a)(11) of the Securities Act, and any commissions
received by them and any profit realized on the resale of the Common Shares sold by them while acting as principals might be deemed to be underwriting discounts or commissions under the Securities Act. As underwriters, the Placement Agents would be
required to comply with the requirements of the Securities Act and the Exchange Act, including, without limitation, Rule 415(a)(4) under the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities Act and Rule <FONT STYLE="white-space:nowrap">10b-5</FONT> and Regulation M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of our
securities by the Placement Agents acting as principals. Under these rules and regulations, the Placement Agents: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">must not engage in any stabilization activity in connection with our securities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">must not bid for or purchase any of our securities or attempt to induce any person to purchase any of our
securities, other than as permitted under the Exchange Act, until they have completed their participation in the distribution. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to
indemnify the Placement Agents and other specified persons against certain civil liabilities, including liabilities under the Securities Act and the Exchange Act. We have also agreed to contribute to payments the Placement Agents may be required to
make in respect of such liabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed with each purchaser and the Placement Agents for a period of 75 days after the closing of this offering not to issue any Common
Shares or any securities equivalent to the Common Shares, except that such restriction shall not apply with respect to the issuance of (i)&nbsp;Common Shares in this offering, (ii)&nbsp;Common Shares or options to employees, officers, consultants or
directors of the Company pursuant to any stock or option plan or arrangement duly adopted for such purpose, by a majority of the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the our board of directors or a majority of the members
of a committee of <FONT STYLE="white-space:nowrap">non-employee</FONT> directors established for such purpose for services rendered to the Company, <FONT STYLE="white-space:nowrap">(iii)&nbsp;non-registered</FONT> equity or debt securities in
connection with strategic transactions, (iv)&nbsp;securities upon the exercise or exchange of or conversion of any securities exercisable or exchangeable for or convertible into Common Shares issued and outstanding on the date hereof, provided that
such securities have not been amended since the date hereof to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or
combinations or anti-dilution provisions contained therein and disclosed in the SEC Reports) or to extend the term of such securities, and (v)&nbsp;securities issued pursuant to acquisitions or strategic transactions approved by a majority of the
disinterested directors of the Company, provided that any such issuance shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital. The purchasers which purchased a majority of the Common
Shares in the offering and the Placement Agents may also at any time or from time to time before the termination of the <FONT STYLE="white-space:nowrap">lock-up</FONT> period waive such restrictions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Distribution </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
supplement and the accompanying prospectus may be made available in electronic format on websites or through other online services maintained by the Placement Agents, or by their affiliates. Other than this prospectus supplement and the accompanying
prospectus in electronic format, the information on the Placement Agents&#146; websites and any information contained in any other website maintained by the Placement Agents is not part of this prospectus supplement and the accompanying prospectus
or the registration statement of which this prospectus supplement and the accompanying prospectus form a part, has not been approved and/or endorsed by us or the Placement Agents, and should not be relied upon by investors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing does not purport to be a complete statement of the terms and conditions of the placement agent agreement and securities purchase
agreements. A copy of the placement agent agreement and the form of securities purchase agreement with the investors will be included as exhibits to our current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that will be filed with the
SEC and incorporated by reference into the Registration Statement of which this prospectus supplement forms a part. See &#147;Where You Can Find More Information&#148; on page <FONT STYLE="white-space:nowrap">S-18.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Activities and Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Placement Agents and certain of their affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. From time to time, the Placement Agents and their affiliates
have provided, and may in the future provide, various investment banking, financial advisory and other services to us and our affiliates for which services they have received, and may in the future receive, customary fees. In the ordinary course of
its businesses, the Placement Agents and certain of their affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for
their own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments issued by us and our affiliates. If the Placement Agents or their affiliates have a lending
relationship with us, they routinely hedge their credit exposure to us consistent with their customary risk management policies. The Placement Agents and their affiliates may hedge such exposure by entering into transactions that consist of either
the purchase of credit default swaps or the creation of short positions in our securities or the securities of our affiliates, including potentially the Common Shares offered hereby. Any such short positions could adversely affect future trading
prices of the Common Shares offered hereby. The Placement Agents and certain of their affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in
respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We paid A.G.P./Alliance Global Partners $3.1 million for commissions and expense reimbursement in connection with our September 2020 offering
of units. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_10"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the securities offered in this prospectus will be passed upon for us by Torys LLP, Toronto, Ontario and New York, New York.
The Placement Agents are being represented by Sullivan&nbsp;&amp; Worcester LLP, New York, New York. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_11"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of the Company and Pure Sunfarms incorporated in this prospectus supplement by reference to the Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> of the Company for the year ended December&nbsp;31, 2019 have been so incorporated in reliance on the reports of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the
authority of said firm as experts in auditing and accounting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_12"></A>WHERE YOU CAN FIND MORE INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the information requirements of the Exchange Act and, accordingly, we file reports with and furnish other
information to the SEC. We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act with respect to the Common Shares offered by this prospectus supplement. This prospectus
supplement and the accompany prospectus does not contain all of the information contained in the registration statement that we filed. For further information regarding us and the securities covered by this prospectus supplement and the accompany
prospectus, you may desire to review the full registration statement, including its exhibits. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file
electronically with the SEC, including the registration statement and its exhibits. The SEC&#146;s website address is http://www.sec.gov. We maintain a website at www.villagefarms.com. Information contained in or accessible through our website does
not constitute a part of this prospectus supplement and the accompany prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc88408_13"></A>INCORPORATION OF
INFORMATION BY REFERENCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are allowed to incorporate by reference information contained in documents that we file with the SEC.
This means that we can disclose important information to you by referring you to those documents and that the information in this prospectus supplement is not complete and you should read the information incorporated by reference for more detail.
Information in this prospectus supplement supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus supplement, while information that we file later with the SEC will automatically update and
supersede the information in this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate by reference the documents listed below and any future filings we
will make with the SEC under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act from the date of this prospectus supplement but prior to the termination of the offering of the securities covered hereby (other than Current Reports or portions
thereof furnished under Item 2.02 or 7.01 of Form <FONT STYLE="white-space:nowrap">8-K,</FONT> or corresponding information furnished under Item 9.01 or included as an exhibit): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520094235/d853826d10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2019, filed with the SEC on April&nbsp;1, 2020, as amended on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520130982/d859552d10ka.htm">Form <FONT
STYLE="white-space:nowrap">10-K/A</FONT></A>, filed with the SEC on May&nbsp;1, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520142930/d900101d10q.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended March&nbsp;31, 2020, filed on May&nbsp;14, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520217851/d905928d10q.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended June&nbsp;30, 2020, filed on August&nbsp;13, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000156459020053721/vff-10q_20200930.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended September&nbsp;30, 2020, filed on November&nbsp;13, 2020; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520009121/d874840d8k.htm">January
<U></U>&nbsp;17, 2020</A> (Item 8.01 only), <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520061806/d895071d8k.htm">March<U></U>&nbsp;
4, 2020</A> (Item 1.01 only), <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520071693/d859325d8k.htm">March<U></U>&nbsp;
12, 2020</A> (Item 8.01 only), <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520079239/d898470d8k.htm">March<U></U>&nbsp;
19, 2020</A> (Items 1.01 and 8.01 only), <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520083448/d823899d8k.htm">March<U></U>&nbsp;
24, 2020</A><U> </U>(Item 8.01 only), <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520091128/d910378d8k.htm">March<U></U>&nbsp;
30, 2020</A> (Item 8.01 only), <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520115018/d918314d8k.htm">April<U></U>&nbsp;
22, 2020</A> (Item 5.02 only), <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520130952/d919420d8k.htm">May<U></U>&nbsp;
1, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520159823/d908739d8k.htm">June<U></U>&nbsp;4, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520179156/d76375d8k.htm">June<U></U>&nbsp;25,
2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520187997/d939335d8k.htm">July<U></U>&nbsp;
7, 2020</A> (Item 2.03 only), <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520192606/d29977d8k.htm">July<U></U>&nbsp;
14, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520242685/d72600d8k.htm">September<U></U>&nbsp;
10, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000156459020049637/vff-8k_20201102.htm">November<U></U>&nbsp;
2, 2020</A> (Items 1.01, 1.02, 2.01 and 2.03 only), and <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000156459020057493/vff-8ka_20201102.htm">December<U></U>&nbsp;17, 2020</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our Common Shares set forth under the heading &#147;Capital Structure&#148; contained in our
Annual Information Form dated April&nbsp;
2, 2018, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312519012906/d647924dex9910.htm">Exhibit 99.10</A> to our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312519012906/d647924d40fr12b.htm">Form
 40FR12B</A> filed on January&nbsp;
18, 2019, as updated by <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520094235/d853826dex42.htm">Exhibit 4.2</A> to our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520094235/d853826d10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2019, filed with the SEC on April&nbsp;1, 2020, including any amendment thereto filed for the purpose of amending such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not authorized anyone to provide you with any different or additional information other than that contained in or incorporated by
reference into this prospectus supplement and the accompanying prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any information that others may provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement contained in a document incorporated or deemed to be incorporated by reference into this prospectus supplement and the
accompanying prospectus will be deemed to be modified or superseded for purposes of this prospectus supplement and the accompany prospectus to the extent that a statement contained in this prospectus supplement and the accompany prospectus or any
other subsequently filed document that is deemed to be incorporated by reference into this prospectus supplement and the accompany prospectus modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as
so modified or superseded, to constitute a part of this prospectus supplement and the accompany prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The documents incorporated by
reference into this prospectus supplement and the accompany prospectus are available from us upon request. We will provide a copy of any and all of the information that is incorporated by reference into this prospectus supplement and the accompany
prospectus but not delivered with this prospectus supplement and the accompany prospectus to any person, including a beneficial owner, to whom this prospectus supplement and the accompany prospectus is delivered, without charge, upon written or oral
request. If exhibits to the documents incorporated by reference into this prospectus supplement and the accompany prospectus are not themselves specifically incorporated by reference in this prospectus supplement and the accompany prospectus, then
the exhibits will not be provided. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Requests for any of these documents should be directed to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Village Farms International, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4700-80th Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Delta, British
Columbia, Canada </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V4K 3N3 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(604) <FONT STYLE="white-space:nowrap">940-6012</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g88408g37c77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>VILLAGE FARMS INTERNATIONAL, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>$200,000,000 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common
Shares </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preferred Shares </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Subscription
Receipts </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Village Farms
International, Inc. (the &#147;<B>Company</B>&#148;) or any selling securityholder may offer for sale and issue from time to time (i)&nbsp;common shares in the capital of the Company (the &#147;<B>Common Shares</B>&#148;), (ii) preferred shares in
the capital of the Company (the &#147;<B>Preferred Shares</B>&#148;), (iii) warrants to purchase Common Shares, Preferred Shares or other securities of the Company (&#147;<B>Warrants</B>&#148;), (iv) subscription receipts, each of which, once
purchased, will entitle the holder to receive upon satisfaction of certain release conditions, and for no additional consideration, one Common Share and/or other securities of the Company (&#147;<B>Subscription Receipts</B>&#148;), (v) debt
securities of the Company (&#147;<B>Debt Securities</B>&#148;), and (vi)&nbsp;securities comprised of more than one of Common Shares, Preferred Shares, Warrants, Subscription Receipts and Debt Securities offered together as a unit
(&#147;<B>Units</B>&#148; and, collectively with the Common Shares, Preferred Shares, Warrants, Subscription Receipts and Debt Securities, the &#147;<B>Securities</B>&#148;), or any combination thereof, up to an aggregate initial offering price of
$200,000,000 (or the equivalent amount if any Securities are issued for consideration in another currency). The Securities may be offered in amounts, at prices and on terms to be determined based on market conditions at the time of sale and set
forth in an accompanying prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus (&#147;<B>Prospectus</B>&#148;) provides you with a general description
of the Securities that we may offer. Each time we offer Securities, we will provide you with a prospectus supplement that describes specific information about the particular Securities being offered and may add, update or change information
contained or incorporated by reference in this Prospectus (each a &#147;<B>Prospectus Supplement</B>&#148;). You should read both this Prospectus and the applicable Prospectus Supplement, together with the additional information that is incorporated
by reference into this Prospectus and the applicable Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common shares are listed on the Nasdaq Capital Market of
The Nasdaq Stock Market LLC (&#147;<B>NASDAQ</B>&#148;) and on the Toronto Stock Exchange under the symbol &#147;VFF&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing
in our Securities involves a high degree of risk. You should carefully read the &#147;<A HREF="#rom88408_4">Risk Factors</A>&#148; section of this Prospectus beginning on page 2. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this
Prospectus is April 22, 2020.</B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_1">FORWARD-LOOKING STATEMENTS </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_2">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iv</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_3">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_5">ENFORCEABILITY OF CIVIL LIABILITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_7">DESCRIPTION OF COMMON SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_8">DESCRIPTION OF PREFERRED SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_9">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_10">DESCRIPTION OF SUBSCRIPTION RECEIPTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_11">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_12">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_13">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_14">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_15">MATERIAL INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_16">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_17">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_18">WHERE YOU CAN FIND ADDITIONAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom88408_19">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_1"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus and the documents that are incorporated by reference into this Prospectus contain forward-looking statements within the
meaning of the<I> </I>United States Private Securities Litigation Reform Act of 1995, Section&nbsp;27A of the U.S. Securities Act of 1933 (the &#147;<B>Securities Act</B>&#148;) and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended
(the &#147;<B>Exchange Act</B>&#148;), and is subject to the safe harbor created by those sections. This Prospectus and the documents that are incorporated by reference into this Prospectus also contain &#147;forward-looking information&#148; within
the meaning of applicable Canadian securities laws. Such forward-looking statements and forward-looking information are collectively referred to herein as &#147;forward-looking statements&#148;. Forward-looking statements may relate to our future
outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures,
financial results, taxes, plans and objectives of ours or involving us. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for us, the greenhouse vegetable industry or the cannabis industry are
forward-looking statements. In some cases, forward-looking information can be identified by such terms as &#147;outlook&#148;, &#147;may&#148;, &#147;might&#148;, &#147;will&#148;, &#147;could&#148;, &#147;should&#148;, &#147;would&#148;,
&#147;occur&#148;, &#147;expect&#148;, &#147;plan&#148;, &#147;anticipate&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;try&#148;, &#147;estimate&#148;, &#147;predict&#148;, &#147;potential&#148;, &#147;continue&#148;, &#147;likely&#148;,
&#147;schedule&#148;, &#147;objectives&#148;, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this Prospectus and the documents that
are incorporated by reference into this Prospectus are subject to risks that may include, but are not limited to: our limited operating history, including that of our Pure Sunfarms Corp. joint venture for the production of cannabis in Canada (our
&#147;<B>Joint Venture</B>&#148;) and our <FONT STYLE="white-space:nowrap">start-up</FONT> operations of growing hemp in the United States; the legal status of our Joint Venture; risks relating to obtaining additional financing, including our
dependence upon credit facilities; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp and agricultural businesses; the ability of our Joint Venture to cultivate
and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and licenses (e.g., our Joint Venture&#146;s ability to obtain licenses for its Delta 2 greenhouse facility as well as
additional licenses under the <I>Canadian act respecting cannabis to amend to the Controlled Drugs and Substances Act, the Criminal Code and other Acts</I>, S.C. 2018, c. 16 (Canada) for its Delta 3 greenhouse facility), and changes in our
regulatory requirements; risks relating to conversion of our greenhouses to cannabis production for our Joint Venture; risks related to rules and regulations at the U.S. federal (Food and Drug Administration and United States Department of
Agriculture), state and municipal levels with respect to produce and hemp; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key
executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth;
restrictive covenants under our credit facilities; natural catastrophes; the ongoing and developing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; and tax risks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have based these forward-looking statements on factors and assumptions about future events and financial trends that we believe may affect
our financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this Prospectus and in the documents incorporated by reference herein are based upon assumptions that
management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known
and unknown risks and uncertainties, many of which are beyond our control, that may cause our or the industry&#146;s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed
or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in our filings with the Securities and Exchange Commission (the &#147;<B>SEC</B>&#148;), including this Prospectus and
the documents that are incorporated by reference into this Prospectus. In particular, we caution you that our forward-looking statements are subject to the ongoing and developing circumstances related to the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, which may have a material adverse effect on our business, operations and future financial results. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When relying on forward-looking statements to make decisions, we caution readers not to
place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking
statements made in this Prospectus and in the documents incorporated by reference herein relate only to events or information as of the date on which the statements are made in this Prospectus or the respective date of the applicable document
incorporated by reference herein. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the
statements are made or to reflect the occurrence of unanticipated events. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_2"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus is a part of a registration statement that we have filed with the SEC utilizing a &#147;shelf&#148; registration process.
Under this shelf registration process, we may sell any combination of the Securities described in this Prospectus in one or more offerings up to an aggregate initial offering price of $200,000,000. The Securities may also be resold by selling
securityholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus provides you with a general description of the Securities that we may sell under this Prospectus. Each
time we sell Securities, we may also provide a Prospectus Supplement that may include, where applicable, specific information about the terms of that offering. If there is any inconsistency between the information in this Prospectus and any
applicable Prospectus Supplement, you should rely on the information in the Prospectus Supplement. Where required by statute, regulation or policy, and where Securities are offered in currencies other than U.S. dollars, appropriate disclosure of
foreign exchange rates applicable to those Securities will be included in the Prospectus Supplement describing those Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may
also prepare free writing Prospectuses to describe the terms of particular sales of Securities, which terms may vary from those described in any Prospectus Supplement. You therefore should carefully review any free writing Prospectus in connection
with your review of this Prospectus and any applicable Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please carefully read both this Prospectus and any
Prospectus Supplement, together with the documents incorporated by reference into this Prospectus and any Prospectus Supplement, and the additional information described below under &#147;Where You Can Find Additional Information&#148;. This
Prospectus contains summaries of certain provisions contained in some of the documents described in this Prospectus, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the
actual documents. Copies of some of the documents referred to in this Prospectus have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this Prospectus is a part, and you may obtain
copies of those documents as described below under &#147;Where You Can Find Additional Information&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the
information contained in or incorporated by reference into this Prospectus and any Prospectus Supplement. We have not authorized anyone to provide you with different information. The distribution or possession of this Prospectus in or from certain
jurisdictions may be restricted by law. This Prospectus is not an offer to sell any Securities and is not soliciting an offer to buy Securities in any jurisdiction where the offer or sale is not permitted or where the person making the offer or sale
is not qualified to do so or to any person to whom it is not permitted to make such offer or sale. The information contained in this Prospectus is accurate only as of the date of this Prospectus and any information incorporated by reference into
this Prospectus is accurate only as of the date of the applicable document incorporated by reference, regardless of the time of delivery of this Prospectus or of any sale of the Securities. Our business, financial condition, results of operations
and prospects may have changed since that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Prospectus and in any Prospectus Supplement, unless the context otherwise
requires, the terms &#147;Village Farms&#148;, the &#147;Company&#148;, &#147;we&#148;, &#147;us&#148;, and &#147;our&#148; refer to Village Farms International, Inc., and, unless the context requires otherwise, the subsidiaries through which it
conducts business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The complete mailing address and telephone number of our principal executive officers is: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Village Farms International, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4700-80th Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Delta, British
Columbia, Canada </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V4K 3N3 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(604) <FONT STYLE="white-space:nowrap">940-6012</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Unless stated otherwise or if the context otherwise requires, all references to dollar amounts in this Prospectus and any Prospectus
Supplement are references to U.S. dollars. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_3"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary does not contain all the information about us that may be important to you. Please carefully read both this Prospectus and any
Prospectus Supplement together with the additional information contained in or incorporated by reference into this Prospectus and any Prospectus Supplement. </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a
corporation existing under the<I> Canada Business Corporations Act </I>(the &#147;<B>CBCA</B>&#148;). Our head and registered office and each of our Canadian subsidiaries is located at 4700-80th Street, Delta, British Columbia, Canada, V4K 3N3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through our majority ownership position in our joint venture, the British Columbia-based Pure Sunfarms Corp. (our &#147;<B>Joint
Venture</B>&#148; or &#147;<B>Pure Sunfarms</B>&#148;), we have one of the single largest cannabis growing operations in the world. We are also one of the largest and longest-operating vertically integrated greenhouse growers in North America and
the only publicly traded greenhouse produce company in Canada, and we have joint venture operations in hemp and CBD products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Joint
Venture leverages our 30 years of experience as a vertically integrated greenhouse grower for the rapidly emerging cannabis opportunity following legalization of cannabis in Canada. Our Joint Venture is currently one of the largest producers of
cannabis in Canada with distribution in three of the provinces. Its long-term objective is to be the leading low cost, high quality cannabis producer in Canada. In our greenhouse operations, we produce and distribute fresh, premium-quality produce
with consistency 365 days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (&#147;<B>CEA</B>&#148;) greenhouses in British Columbia and Texas, as well as from our partner
greenhouses in British Columbia, Ontario and Mexico. We are also pursuing opportunities to become a vertically integrated leader in the U.S. hemp-derived CBD market, subject to compliance with all applicable U.S. federal and state laws. We have
established two joint ventures, Village Fields Hemp USA, LLC, and Arkansas Valley Green and Gold Hemp LLC, for multi-state outdoor hemp cultivation and CBD extraction and plans to pursue controlled environment hemp production at our Texas greenhouse
operations, which total 5.7&nbsp;million square feet of production area, subject to legalization of hemp in Texas. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further information
regarding the Company and its business is set out in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> which is incorporated herein by reference. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Securities described herein may be offered from time to time in one or more offerings utilizing a &#147;shelf&#148; process under Canadian and U.S. securities laws. Under this shelf process, this Prospectus provides you with a general description of
the Securities that we may offer. Each time we sell Securities, we will provide a Prospectus Supplement that will contain specific information about the terms of that offering. The Prospectus Supplement may also add, update or change information
contained in this Prospectus. You should read both this Prospectus and any Prospectus Supplement. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in our Securities involves a significant degree of risk. You should carefully consider the risk factors and all of the other
information included in this Prospectus, any Prospectus Supplement, the documents we have incorporated by reference into this Prospectus and any Prospectus Supplement, and in any related free writing Prospectus, including those in Item 1A &#147;Risk
Factors&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2019, as updated by annual, quarterly and other reports and documents we file with the SEC after the date of this
Prospectus and that are incorporated by reference into this Prospectus, in evaluating an investment in our Securities. If any of these risks were actually to occur, our business, financial condition or results of operations could be materially
adversely affected. When we offer and sell any Securities pursuant to a Prospectus Supplement, we may include in the applicable Prospectus Supplement additional risk factors relevant to those Securities. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_5"></A>ENFORCEABILITY OF CIVIL LIABILITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are incorporated under the laws of Canada. Many of our directors and officers, and many of the experts named in this Prospectus, are
residents of Canada, and all or a substantial portion of their assets and a substantial portion of our assets, are located outside the United States. Consequently, although we have appointed an agent for service of process in the United States, it
may be difficult for holders of our Securities who reside in the United States to effect service within the United States upon our directors, officers and experts who are not residents of the United States. It may also be difficult for holders of
our Securities who reside in the United States to realize in the United States upon judgments of courts of the United States predicated upon our civil liability and the civil liability of our directors, officers and experts under the United States
federal securities laws. Investors should not assume that Canadian courts (i)&nbsp;would enforce judgments of United States courts obtained in actions against us or our directors, officers or experts predicated upon the civil liability provisions of
the United States federal securities laws or the securities or &#147;blue sky&#148; laws of any state within the United States or (ii)&nbsp;would enforce, in original actions, liabilities against us or our directors, officers or experts predicated
upon the United States federal securities laws or any such state securities or &#147;blue sky&#148; laws. In addition, we have been advised by our Canadian counsel that in normal circumstances, only civil judgments and not other rights arising from
United States securities legislation are enforceable in Canada and that the protections afforded by Canadian securities laws may not be available to investors in the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in a Prospectus Supplement, the net proceeds that we receive from the sale of our Securities will be used for
working capital and general corporate purposes. Unless otherwise indicated in a Prospectus Supplement, our management will have broad discretion to allocate the net proceeds of the sale of our Securities. More specific allocations may be included in
a Prospectus Supplement relating to a specific offering of Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise set forth in the applicable prospectus
supplement, we will not receive any proceeds in the event that securities are sold by a selling securityholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_7"></A>DESCRIPTION OF COMMON SHARES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue an unlimited number of Common Shares, no par value. As of April 21, 2020, the Company had 56,300,419 Common
Shares outstanding. Each Common Share entitles the holder thereof to receive notice of and to attend all meetings of shareholders of the Company and to one vote per Common Share at such meetings (other than meetings at which only the holders of
another class of shares are entitled to vote separately as a class). The Common Shares entitle the holders thereof to receive, in any year, dividends on the Common Shares as and when declared by the board of directors of the Company, provided that
payment of such dividends is not prohibited under law and after payment of any applicable amounts to which holders of any Preferred Shares may be entitled. In the event of the liquidation, dissolution or
<FONT STYLE="white-space:nowrap">winding-up</FONT> of the Company, whether voluntary or involuntary, after payment of or other proper provision for all of the liabilities of the Company and the payment of any amounts payable to holders of the
Preferred Shares, the holders of the Common Shares will be entitled to share <I>pro rata</I> in all remaining property or assets of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have no current plans to pay dividends as we are growth focused. The amount of any dividends payable by us will be at the discretion of our
board of directors and may vary depending on, among other things, our earnings, financial requirements for our operations, growth opportunities, debt covenants, the satisfaction of the solvency tests imposed by the CBCA for declaration and payment
of dividends and the conditions existing from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further information relating to the Common Shares and the share capital of
the Company is set out in the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> which is incorporated by reference herein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_8"></A>DESCRIPTION OF PREFERRED SHARES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue an unlimited number of Preferred Shares. The Company&#146;s board of directors will fix the number of
Preferred Shares, as well as the designation, rights, privileges, restrictions and conditions for each series of Preferred Shares that may be issued, subject to the Company filing the applicable articles of amendment under the CBCA. Preferred Shares
will have preference over Common Shares with respect to the payment of dividends and in the distribution of assets in the event of the liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of the Company, be it voluntary or
involuntary, or any other distribution of the assets of the Company among its shareholders for the purpose of <FONT STYLE="white-space:nowrap">winding-up</FONT> its affairs. Preferred Shares will have no right to vote on shareholder matters, subject
to certain exceptions. No changes to the provisions of the Preferred Shares may be made without the approval of the holders of the Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Prospectus Supplement will set forth the following terms relating to the Preferred Shares being offered: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the maximum number of Preferred Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation of the series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the offering price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the annual dividend rate and whether the dividend rate is fixed or variable, the date from which dividends will
accrue and the dividend payment dates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price and terms and conditions for redemption, if any, including redemption at the Company&#146;s option or
at the option of the holder, including the time period for redemption, and payment of any accumulated dividends; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such Preferred Shares will be subject to any restriction on the repurchase or redemption while there is
any arrearage in the payment of dividends or sinking fund installments; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms and conditions, if any, for conversion or exchange for shares of any other class of the Company or any
other series of Preferred Shares, or any other securities or assets, including the price or the rate of conversion of exchange and the method, if any, of adjustment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such Preferred Shares will be listed on any securities exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the voting rights, if any; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other rights, privileges, restrictions, or conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preferred Shares will be fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> securities upon issuance. The Preferred Shares
of any series may be represented in whole or in part, by one or more global certificates. If Preferred Shares are represented by a global certificate, each global certificate will: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be registered in the name of a depository or a nominee of the depository identified in the applicable Prospectus
Supplement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be deposited in the name of a depository or a nominee of the depository identified in the applicable Prospectus
Supplement. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_9"></A>DESCRIPTION OF WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may issue Warrants
independently or together with other securities, and Warrants sold with other securities may be attached to or separate from the other securities. Warrants will be issued under one or more warrant agreements between the Company and a warrant agent
that the Company will name in the applicable Prospectus Supplement. The Company will file any warrant agreement or warrant indenture with the SEC and incorporate them by reference as an exhibit to the registration statement of which this prospectus
is a part, on or before the time we issue a series of warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Prospectus Supplement will set forth the following terms relating to
the Warrants being offered: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation of the Warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate number of Warrants offered and the offering price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation, number and terms of the Common Shares, Preferred Shares or other securities purchasable upon
exercise of the Warrants, and procedures that will result in the adjustment of those numbers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exercise price of the Warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the various factors considered in determining the exercise price of the Warrants, to the extent such exercise
prices are variable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions for changes to or adjustments in the exercise price, if any; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates or periods during which the Warrants are exercisable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and terms of any securities with which the Warrants are issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Warrants are issued as a unit with another security, the date on and after which the Warrants and the
other security will be separately transferable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency or currency unit in which the exercise price is denominated; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any minimum or maximum amount of Warrants that may be exercised at any one time; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such Warrants will be listed on any securities exchange; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any terms, procedures and limitations relating to the transferability, exchange or exercise of the Warrants;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limitations on the right of <FONT STYLE="white-space:nowrap">non-resident</FONT> or foreign owners to hold
such Warrants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of Warrants outstanding, if any; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the Warrants. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Warrant certificates will be exchangeable for new warrant certificates of different denominations at the office indicated in the Prospectus
Supplement. Prior to the exercise of their Warrants, holders of Warrants will not have any of the rights of holders of the securities subject to the Warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modifications </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may amend the
warrant agreements and the Warrants, without the consent of the holders of the Warrants, to cure any ambiguity, to cure, correct or supplement any defective or inconsistent provision, or in any other manner that will not materially and adversely
affect the interests of holders of outstanding Warrants. Other amendment provisions shall be as indicated in the Prospectus Supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Enforceability
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrant agent will act solely as the Company&#146;s agent. The warrant agent will not have any duty or responsibility if the
Company defaults under the warrant agreements or the warrant certificates. A Warrant holder may, without the consent of the warrant agent, enforce by appropriate legal action on its own behalf the holder&#146;s right to exercise the holder&#146;s
Warrants. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_10"></A>DESCRIPTION OF SUBSCRIPTION RECEIPTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subscription Receipts may be offered separately or together with Common Shares and/or other securities of the Company, including Warrants. The
Subscription Receipts will be issued under a subscription receipt agreement that will be entered into by the Company and an escrow agent at the time of issuance of the Subscription Receipts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Subscription Receipt will entitle the holder thereof to receive a Common Share and/or other securities of the Company, for no additional
consideration, upon the completion of a particular transaction or event, typically an acquisition of the assets or securities of another entity by the Company or one or more of its subsidiaries. The subscription proceeds from an offering of
Subscription Receipts will be held in escrow by an escrow agent pending the completion of a transaction or the termination time (the time at which the escrow terminates regardless of whether the transaction or event has occurred). Holders of
Subscription Receipts will receive Common Shares and/or other securities of the Company upon the completion of the particular transaction or event or, if the transaction or event does not occur by the termination time, a return of the subscription
funds for their Subscription Receipts together with any interest or other income earned thereon. Holders of Subscription Receipts are not shareholders of the Company simply by virtue of holding a Subscription Receipt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The particular terms and provisions of Subscription Receipts offered by any Prospectus Supplement, and the extent to which the general terms
and provisions described below may apply to them, will be described in the Prospectus Supplement filed in respect of such Subscription Receipts. The description will include, where applicable: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of Subscription Receipts offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which the Subscription Receipts will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the various factors considered in determining the price of the Subscription Receipts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions for changes to or adjustments in the price, if any; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, conditions and procedures pursuant to which the holders of Subscription Receipts will become entitled
to receive Common Shares and/or other securities of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of Common Shares and/or other securities of the Company that may be obtained upon exercise of each
Subscription Receipt; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and terms of any other securities with which the Subscription Receipts will be offered, if any,
and the number of Subscription Receipts that will be offered with each such security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms relating to the holding and release of the gross proceeds from the sale of the Subscription Receipts
plus any interest and income earned thereon; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material income tax consequences of owning, holding and disposing of the Subscription Receipts;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of Subscription Receipts outstanding, if any; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limitations on the right of <FONT STYLE="white-space:nowrap">non-resident</FONT> or foreign owners to hold
such Subscription Receipts; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms and conditions of the Subscription Receipts including, without limitation,
transferability and adjustment terms and whether the Subscription Receipts will be listed on any securities exchange. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_11"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this description of debt securities section, &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; or &#147;Village Farms&#148; or &#147;the
Company&#148; refer to Village Farms International, Inc. but not to its subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section describes the general terms that will
apply to any debt securities issued pursuant to this Prospectus. We may issue debt securities in one or more series under an indenture to be entered into between us and one or more trustees, at least one of which will be qualified to act as a U.S.
trustee and one of which will be qualified to act as a Canadian trustee. References herein to the &#147;trustee&#148; shall be deemed to mean the U.S. trustee and/or the Canadian trustee. The indenture will be subject to and governed by the United
States Trust Indenture Act of 1939, as amended (the &#147;<B>Trust Indenture Act</B>&#148;), and the CBCA. A copy of the form of the indenture is filed with the SEC as an exhibit to the registration statement of which this Prospectus forms a part.
The following description sets forth certain general terms and provisions of the debt securities. Prospective investors should also refer to the indenture and the terms of the debt securities. If debt securities are issued, we will describe in the
applicable Prospectus Supplement the particular terms and provisions of any series of the debt securities and a description of how the general terms and provisions described below may apply to that series of the debt securities. Prospective
investors should rely on information in the applicable Prospectus Supplement and not on the following information to the extent that the information in such Prospectus Supplement is different from the following information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue debt securities and incur additional indebtedness other than through the offering of debt securities pursuant to this Prospectus.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture will not
limit the aggregate principal amount of debt securities that we may issue under the indenture and will not limit the amount of other indebtedness that we may incur. The indenture will provide that we may issue debt securities from time to time in
one or more series and may be denominated and payable in U.S. dollars, Canadian dollars or any foreign currency. Unless otherwise indicated in the applicable Prospectus Supplement, the debt securities will be our unsecured obligations. The indenture
will also permit us to increase the principal amount of any series of the debt securities previously issued and to issue that increased principal amount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable Prospectus Supplement for any series of debt securities that we offer will
describe the specific terms of the debt securities and may include, but is not limited to, any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate principal amount of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the percentage of principal amount at which the debt securities will be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether payment on the debt securities will be senior or subordinated to our other liabilities or obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the payment of the debt securities will be guaranteed by any other person; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates, or the methods by which such dates will be determined or extended, on which we may issue the
debt securities and the date or dates, or the methods by which such dates will be determined or extended, on which we will pay the principal and any premium on the debt securities, or the portion (if less than the principal amount) of debt
securities, in each case, to be payable upon a declaration of acceleration of maturity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities will bear interest, the interest rate (whether fixed or variable) or the method of
determining the interest rate, the date from which interest will accrue, the dates on which we will pay interest and the record dates for interest payments, or the methods by which such dates will be determined or extended; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places we will pay principal, premium, if any, and interest and the place or places where debt
securities can be presented for registration of transfer or exchange; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether and under what circumstances we will be required to pay any additional amounts for withholding or
deduction for Canadian or other taxes with respect to the debt securities, and whether and on what terms we will have the option to redeem the debt securities rather than pay the additional amounts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will be obligated to redeem or repurchase the debt securities pursuant to any sinking or purchase fund
or other provisions, or at the option of a holder and the terms and conditions of such redemption; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms and conditions of any mandatory or optional redemption by the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations in which we will issue any registered debt securities, if other than denominations of $1,000
and any multiple of $l,000, the denominations in which any unregistered debt security shall be issuable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will make payments on the debt securities in a currency or currency unit other than U.S. dollars or by
delivery of our common shares or other property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether payments on the debt securities will be payable with reference to any index or formula;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will issue the debt securities as global securities and, if so, the identity of the depositary for the
global securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will issue the debt securities as unregistered securities (with or without coupons), registered
securities or both; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the periods within which and the terms and conditions, if any, upon which we may redeem the debt securities prior
to maturity and the price or prices of which and the currency or currency units in which the debt securities are payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any changes or additions to events of default or covenants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the holders of any series of debt securities have special rights if specified events occur;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, for any conversion or exchange of the debt securities for any other securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rights, if any, on a change of control; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions as to modification, amendment or variation of any rights or terms attaching to the debt securities;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms, conditions, rights and preferences (or limitations on such rights and preferences) including
covenants and events of default which apply solely to a particular series of the debt securities being offered which do not apply generally to other debt securities, or any covenants or events of default generally applicable to the debt securities
which do not apply to a particular series of the debt securities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless stated otherwise in the applicable Prospectus
Supplement, no holder of debt securities will have the right to require us to repurchase the debt securities and there will be no increase in the interest rate if we become involved in a highly leveraged transaction or we have a change of control.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue debt securities bearing no interest or interest at a rate below the prevailing market rate at the time of issuance, and
offer and sell these securities at a discount below their stated principal amount. We may also sell any of the debt securities for a foreign currency or currency unit, and payments on the debt securities may be payable in a foreign currency or
currency unit. In any of these cases, we will describe certain Canadian federal and U.S. federal income tax consequences and other special considerations in the applicable Prospectus Supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue debt securities with terms different from those of debt securities previously issued and, without the consent of the holders
thereof, we may reopen a previous issue of a series of debt securities and issue additional debt securities of such series (unless the reopening was restricted when such series was created). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ranking and Other Indebtedness </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless
otherwise indicated in an applicable Prospectus Supplement, our debt securities will be unsecured obligations and will rank equally with all of our other unsecured and unsubordinated debt from time to time outstanding and equally with other
securities issued under the indenture. The debt securities will be structurally subordinated to all existing and future liabilities, including trade payables, of our subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors may establish the extent and manner, if any, to which payment on or in respect of a series of debt securities will be
senior or will be subordinated to the prior payment of our other liabilities and obligations and whether the payment of principal, premium, if any, and interest, if any, will be guaranteed by any other person and the nature and priority of any
security. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Debt Securities in Global Form </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The
Depositary and Book-Entry </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable Prospectus Supplement, a series of the debt securities may
be issued in whole or in part in global form as a &#147;global security&#148; and will be registered in the name of and be deposited with a depositary, or its nominee, each of which will be identified in the applicable Prospectus Supplement relating
to that series. Unless and until exchanged, in whole or in part, for the debt securities in definitive registered form, a global security may not be transferred except as a whole by the depositary for such global security to a nominee of the
depositary, by a nominee of the depositary to the depositary or another nominee of the depositary or by the depositary or any such nominee to a successor of the depositary or a nominee of the successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The specific terms of the depositary arrangement with respect to any portion of a particular series of the debt securities to be represented
by a global security will be described in the applicable Prospectus Supplement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
relating to such series. We anticipate that the provisions described in this section will apply to all depositary arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the issuance of a global security, the depositary therefor or its nominee will credit, on its book entry and registration system, the
respective principal amounts of the debt securities represented by the global security to the accounts of such persons, designated as &#147;participants,&#148; having accounts with such depositary or its nominee. Such accounts shall be designated by
the underwriters, dealers or agents participating in the distribution of the debt securities or by us if such debt securities are offered and sold directly by us. Ownership of beneficial interests in a global security will be limited to participants
or persons that may hold beneficial interests through participants. Ownership of beneficial interests in a global security will be shown on, and the transfer of that ownership will be effected only through, records maintained by the depositary
therefor or its nominee (with respect to interests of participants) or by participants or persons that hold through participants (with respect to interests of persons other than participants). The laws of some states in the United States may require
that certain purchasers of securities take physical delivery of such securities in definitive form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as the depositary for a
global security or its nominee is the registered owner of the global security, such depositary or such nominee, as the case may be, will be considered the sole owner or holder of the debt securities represented by the global security for all
purposes under the indenture. Except as provided below, owners of beneficial interests in a global security will not be entitled to have a series of the debt securities represented by the global security registered in their names, will not receive
or be entitled to receive physical delivery of such series of the debt securities in definitive form and will not be considered the owners or holders thereof under the indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any payments of principal, premium, if any, and interest, if any, on global securities registered in the name of a depositary or its nominee
will be made to the depositary or its nominee, as the case may be, as the registered owner of the global security representing such debt securities. None of us, the trustee or any paying agent for the debt securities represented by the global
securities will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of the global security or for maintaining, supervising or reviewing any records relating to
such beneficial ownership interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that the depositary for a global security or its nominee, upon receipt of any payment of
principal, premium, if any, or interest, if any, will credit participants&#146; accounts with payments in amounts proportionate to their respective beneficial interests in the principal amount of the global security as shown on the records of such
depositary or its nominee. We also expect that payments by participants to owners of beneficial interests in a global security held through such participants will be governed by standing instructions and customary practices, as is now the case with
securities held for the accounts of customers registered in &#147;street name,&#148; and will be the responsibility of such participants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Discontinuance of Depositary&#146;s Services </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a depositary for a global security representing a particular series of the debt securities is at any time unwilling or unable to continue as
depositary and a successor depositary is not appointed by us within 90 days, we will issue such series of the debt securities in definitive form in exchange for a global security representing such series of the debt securities. If an event of
default under the indenture has occurred and is continuing, debt securities in definitive form will be printed and delivered upon written request by the holder to the trustee. In addition, we may at any time and in our sole discretion determine not
to have a series of the debt securities represented by a global security and, in such event, will issue a series of the debt securities in definitive form in exchange for all of the global securities representing that series of debt securities. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Debt Securities in Definitive Form </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A series of the debt securities may be issued in definitive form, solely as registered securities, solely as unregistered securities or as both
registered securities and unregistered securities. Registered securities will be issuable in denominations of $1,000 and integral multiples of $1,000 or in such other denominations as may be set out in the terms of the debt securities of any
particular series. Unless otherwise indicated in the applicable Prospectus Supplement, unregistered securities will have interest coupons attached. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable Prospectus Supplement, payment of principal, premium, if any, and interest, if any, on the debt
securities (other than global securities) will be made at the office or agency of the trustee, or at our option we can pay principal, interest, if any, and premium, if any, by check mailed or delivered to the address of the person entitled at the
address appearing in the security register of the trustee or electronic funds wire or other transmission to an account of the person entitled to receive payments. Unless otherwise indicated in the applicable Prospectus Supplement, payment of
interest, if any, will be made to the persons in whose name the debt securities are registered at the close of business on the day or days specified by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the option of the holder of debt securities, registered securities of any series will be exchangeable for other registered securities of
the same series, of any authorized denomination and of a like aggregate principal amount and tenor. If, but only if, provided in an applicable Prospectus Supplement, unregistered securities (with all unmatured coupons, except as provided below, and
all matured coupons in default) of any series may be exchanged for registered securities of the same series, of any authorized denominations and of a like aggregate principal amount and tenor. In such event, unregistered securities surrendered in a
permitted exchange for registered securities between a regular record date or a special record date and the relevant date for payment of interest shall be surrendered without the coupon relating to such date for payment of interest, and interest
will not be payable on such date for payment of interest in respect of the registered security issued in exchange for such unregistered security, but will be payable only to the holder of such coupon when due in accordance with the terms of the
indenture. Unless otherwise specified in an applicable Prospectus Supplement, unregistered securities will not be issued in exchange for registered securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable Prospectus Supplement may indicate the places to register a transfer of the debt securities in definitive form. Except for
certain restrictions set forth in the indenture, no service charge will be payable by the holder for any registration of transfer or exchange of the debt securities in definitive form, but we may, in certain instances, require a sum sufficient to
cover any tax or other governmental charges payable in connection with these transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We shall not be required to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, register the transfer of or exchange any series of the debt securities in definitive form during a period
beginning at the opening of business 15 days before any selection of securities of that series of the debt securities to be redeemed and ending on the relevant redemption date if the debt securities for which such issuance, registration or exchange
is requested may be among those selected for redemption; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">register the transfer of or exchange any registered security in definitive form, or portion thereof, called for
redemption, except the unredeemed portion of any registered security being redeemed in part; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exchange any unregistered security called for redemption except to the extent that such unregistered security may
be exchanged for a registered security of that series and like tenor; provided that such registered security will be simultaneously surrendered for redemption; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, register the transfer of or exchange any of the debt securities in definitive form which have been
surrendered for repayment at the option of the holder, except the portion, if any, thereof not to be so repaid. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Merger, Amalgamation or Consolidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture will provide that we may not consolidate with or amalgamate or merge with or into any other person, enter into any statutory
arrangement with any person or convey, transfer or lease our properties and assets substantially as an entirety to another person, unless among other items: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are the surviving person, or the resulting, surviving or transferee person, if other than us, is organized and
existing under the laws of the United States, any state thereof or the District of Columbia, Canada, or any province or territory thereof, or, if the amalgamation, merger, consolidation, statutory arrangement or other transaction would not impair
the rights of holders, any other jurisdiction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the successor person (if not us) assumes all of our obligations under the debt securities and the indenture by a
supplemental indenture; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or such successor person will not be in default under the indenture immediately after the transaction.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When such a person assumes our obligations in such circumstances, subject to certain exceptions, we shall be discharged
from all obligations under the debt securities and the indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable Prospectus Supplement relating to a particular series of debt securities, the following is a
summary of events which will, with respect to any series of the debt securities, constitute an event of default under the indenture with respect to the debt securities of that series: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we fail to pay principal of, or any premium on, any debt security of that series when it is due and payable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we fail to pay interest or any additional amounts payable on any debt security of that series when it becomes due
and payable, and such default continues for 30 days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we fail to make any required sinking fund or analogous payment for that series of debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we fail to observe or perform any of the covenants described in the section &#147;&#151; Merger, Amalgamation or
Consolidation&#148; for a period of 30 days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we fail to comply with any of our other agreements in the indenture that affect or are applicable to the debt
securities for 60 days after written notice by the trustee or to us and the trustee by holders of at least 25% in aggregate principal amount of the outstanding debt securities of any series affected thereby; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain events involving our bankruptcy, insolvency or reorganization; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other event of default provided for in that series of debt securities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A default under one series of debt securities will not necessarily be a default under another series. The trustee may withhold notice to the
holders of the debt securities of any default, except in the payment of principal or premium, if any, or interest, if any, if in good faith it considers it in the interests of the holders to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an event of default for any series of debt securities occurs and continues, the trustee or the holders of at least 25% in aggregate
principal amount of the debt securities of that series, subject to any subordination provisions, may require us to repay immediately the entire principal and interest and premium, if any, of the debt securities of the series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an event of default relates to events involving our bankruptcy, insolvency or reorganization, the principal of all debt securities will
become immediately due and payable without any action by the trustee or any holder. Subject to certain conditions, the holders of a majority of the aggregate principal amount of the debt securities of the affected series can rescind this accelerated
payment requirement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than its duties in case of a default, the trustee is not obligated to exercise any of
the rights or powers that it will have under the indenture at the request, order or direction of any holders, unless the holders offer the trustee reasonable indemnity. If they provide this reasonable indemnity, the holders of a majority in
aggregate principal amount of any series of debt securities may, subject to certain limitations, direct the time, method and place of conducting any proceeding or any remedy available to the trustee, or exercising any power conferred upon the
trustee, for any series of debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will be required to furnish to the trustee a statement annually as to our compliance with
all conditions and covenants under the indenture and, if we are not in compliance, we must specify any defaults. We will also be required to notify the trustee as soon as practicable upon becoming aware of any event of default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No holder of a debt security of any series will have any right to institute any proceeding with respect to the indenture, or for the
appointment of a receiver or a trustee, or for any other remedy, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holder has previously given to the trustee written notice of a continuing event of default with respect to
the debt securities of the affected series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holders of at least 25% in principal amount of the outstanding debt securities of the series affected by an
event of default have made a written request, and the holders have offered reasonable indemnity, to the trustee to institute a proceeding as trustee; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trustee has failed to institute a proceeding, and has not received from the holders of a majority in
aggregate principal amount of the outstanding debt securities of the series affected by an event of default a direction inconsistent with the request, within 60 days after their notice, request and offer of indemnity. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, such above-mentioned limitations do not apply to a suit instituted by the holder of a debt security for the enforcement of payment of
the principal of or any premium, if any, or interest on such debt security on or after the applicable due date specified in such debt security. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Defeasance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When we use the term
&#147;defeasance,&#148; we mean discharge from some or all of our obligations under the indenture. Unless otherwise specified in the applicable Prospectus Supplement, if we deposit with the trustee sufficient cash or government securities to pay the
principal, interest, if any, premium, if any, and any other sums due to the stated maturity date or a redemption date of the debt securities of a series, then at our option: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will be discharged from the obligations with respect to the debt securities of that series; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will no longer be under any obligation to comply with certain restrictive covenants under the indenture, and
certain events of default will no longer apply to us. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this happens, the holders of the debt securities of the
affected series will not be entitled to the benefits of the indenture except for registration of transfer and exchange of debt securities and the replacement of lost, stolen or mutilated debt securities. These holders may look only to the deposited
fund for payment on their debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To exercise our defeasance option, we must deliver to the trustee: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an opinion of counsel in the United States to the effect that the holders of the outstanding debt securities of
the affected series will not recognize a gain or loss for U.S. federal income tax purposes as a result of a defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been
the case if the defeasance had not occurred; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an opinion of counsel in Canada or a ruling from the Canada Revenue Agency to the effect that the holders of the
outstanding debt securities of the affected series will not recognize income, or a gain or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
loss for Canadian federal, provincial or territorial income or other tax purposes as a result of a defeasance and will be subject to Canadian federal, provincial or territorial income tax and
other tax on the same amounts, in the same manner and at the same times as would have been the case had the defeasance not occurred; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a certificate of one of our officers and an opinion of counsel, each stating that all conditions precedent
provided for relating to defeasance have been complied with. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are to be discharged from our obligations with
respect to the debt securities, and not just from our covenants, the U.S. opinion must be based upon a ruling from or published by the U.S. Internal Revenue Service or a change in law to that effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the delivery of the opinions described above, the following conditions must be met before we may exercise our defeasance
option: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no event of default or event that, with the passing of time or the giving of notice, or both, shall constitute an
event of default shall have occurred and be continuing for the debt securities of the affected series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are not an &#147;insolvent person&#148; within the meaning of applicable bankruptcy and insolvency
legislation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other customary conditions precedent are satisfied. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Modifications
and amendments of the indenture may be made by us and the trustee with the consent of the holders of a majority in aggregate principal amount of the outstanding debt securities of each series affected by the modification. However, without the
consent of each holder affected, no modification may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the stated maturity of the principal of, premium, if any, or any installment of interest, if any, on any
debt security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal, premium, if any, or rate of interest, if any, or any obligation to pay any additional
amounts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the amount of principal of a debt security payable upon acceleration of its maturity;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the place or currency of any payment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">affect the holder&#146;s right to require us to repurchase the debt securities at the holder&#146;s option;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impair the right of the holders to institute a suit to enforce their rights to payment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adversely affect any conversion or exchange right related to a series of debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the percentage of debt securities required to modify the indenture or to waive compliance with certain
provisions of the indenture; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the percentage in principal amount of outstanding debt securities necessary to take certain actions.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of a majority in principal amount of outstanding debt securities of any series may on behalf of the holders
of all debt securities of that series waive, insofar as only that series is concerned, past defaults (other than defaults relating to certain events involving our bankruptcy, insolvency or reorganization) under the indenture and compliance by us
with certain restrictive provisions of the indenture. However, these holders may not waive a default in any payment on any debt security or compliance with a provision that cannot be modified without the consent of each holder affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may modify the indenture without the consent of the holders to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evidence our successor under the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add covenants or surrender any right or power for the benefit of holders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add events of default; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide for unregistered securities to become registered securities under the indenture and make other such
changes to unregistered securities that in each case do not materially and adversely affect the interests of holders of outstanding securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish the form and terms of debt securities of any series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appoint a successor trustee under the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add provisions to permit or facilitate the defeasance or discharge of the debt securities as long as there is no
material adverse effect on the holders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cure any ambiguity, correct or supplement any defective or inconsistent provision, make any other provisions in
each case that would not materially and adversely affect the interests of holders of outstanding securities and related coupons, if any; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">comply with any applicable laws of the United States and Canada in order to effect and maintain the qualification
of the indenture under the Trust Indenture Act; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change or eliminate any provisions where such change takes effect when there are no securities outstanding under
the indenture. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture and the debt securities will be governed by and construed in accordance with the laws of the State of New York. However, the
exercise, performance or discharge by the Canadian trustee of any of its rights, powers, duties or responsibilities under the indenture will be construed in accordance with applicable Canadian laws. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Trustees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will identify the U.S.
trustee and Canadian trustee in the applicable Prospectus Supplement in connection with an offering of debt securities hereunder. In addition, in connection with an offering of debt securities hereunder, the U.S. trustee will be qualified under the
Trust Indenture Act pursuant to Section&nbsp;305(b)(2) of the Trust Indenture Act. The trustees under the indenture or their respective affiliates may provide banking and other services to us in the ordinary course of their business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture will contain certain limitations on the rights of the trustees, as long as the trustees or any of their respective affiliates
remain our creditor, to obtain payment of claims in certain cases or to realize on certain property received on any claim as security or otherwise. The trustees and their respective affiliates will be permitted to engage in other transactions with
us. If the trustees or any such affiliate acquires any conflicting interest and a default occurs with respect to the debt securities, the applicable trustee must eliminate the conflict or resign. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Resignation of Trustee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A trustee may
resign or be removed with respect to one or more series of the debt securities and a successor trustee may be appointed to act with respect to such series. In the event that two or more persons are acting as U.S. trustee or Canadian trustee with
respect to different series of debt securities, each such trustee shall be a trustee of a trust under the indenture separate and apart from the trust administered by any other such trustee, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any action described herein to be taken by the &#147;trustee&#148; may then be taken by each such trustee with respect to, and only with respect to, the one or more series of debt securities for
which it is trustee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consent to Service </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the indenture, we will designate and appoint a U.S. authorized agent upon which process may be served in any
suit or proceeding arising out of or relating to the indenture or the debt securities that may be instituted in any U.S. federal or New York state court located in the Borough of Manhattan, in the City of New York, or brought by the trustees
(whether in their individual capacity or in their capacity as trustee under the indenture), and will irrevocably submit to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such courts. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_12"></A>DESCRIPTION OF UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following sets forth certain general terms and provisions of the Units. The Prospectus Supplement relating to any Units offered will
include specific terms and provisions of the Units being offered thereby, and the extent to which the general terms and provisions described below may apply to them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Prospectus Supplement will set forth, as applicable, the following terms relating to the Units being offered: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate number of Units offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which the Units will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation, number and terms of the Securities comprising the Units; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Units will be issued with any other Securities and, if so, the amount and terms of these Securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terms applicable to the gross or net proceeds from the sale of the Units plus any interest earned thereon;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on and after which the Securities comprising the Units will be separately transferable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Securities comprising the Units will be listed on any securities exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such Units or the Securities comprising the Units are to be issued in registered form, &#147;book-entry
only&#148; form, bearer form or in the form of temporary or permanent global securities and the basis of exchange, transfer and ownership thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any terms, procedures and limitations relating to the transferability, exchange or exercise of the Units;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limitations on the right of <FONT STYLE="white-space:nowrap">non-resident</FONT> or foreign owners to hold
such Units; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain material Canadian tax consequences of owning the Units; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of Units outstanding; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms and conditions of the Units. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_13"></A>SELLING SECURITYHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities may be offered and sold from time to time by the Company and/or by one or more selling securityholders to be identified in the
future. Information about selling securityholders, where applicable, will be set forth in a Prospectus Supplement, in a post-effective amendment or in filings we make with the SEC under the Exchange Act which are incorporated by reference into this
Prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_14"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company or any selling securityholder may offer and sell the Securities to or through underwriters or dealers and also may offer and sell
the Securities directly to purchasers or through agents, or through a combination of any of these methods of sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The distribution of
the Securities of any series may be effected from time to time in one or more transactions at a fixed price or prices or at <FONT STYLE="white-space:nowrap">non-fixed</FONT> prices. If offered on a <FONT STYLE="white-space:nowrap">non-fixed</FONT>
price basis, the Securities may be offered at market prices prevailing at the time of sale, at prices determined by reference to the prevailing price of a specified security in a specified market or at prices to be negotiated with purchasers,
including sales in transactions that are deemed to be <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> distributions&#148; in accordance with Rule 415(a)(4) under the Securities Act, in which case
the compensation payable to an underwriter, dealer or agent in connection with any such sale will be increased or decreased by the amount, if any, by which the aggregate price paid for the Securities by the purchasers exceeds or is less than the
gross proceeds paid by the underwriter, dealer or agent to the Company. The price at which the Securities will be offered and sold may vary from purchaser to purchaser and during the period of distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an underwriter, dealer or agent is utilized in the sale of the Securities being offered by this Prospectus, an underwriting, dealer or
agency agreement will be executed with the applicable underwriter(s), dealer(s) or agent(s) at the time of sale. In connection with the sale of the Securities, underwriters, dealers or agents may receive compensation from the Company or from other
parties, including in the form of underwriters&#146;, dealers or agents&#146; fees, commissions or concessions. Any underwriters, dealers or agents who participate in the sale or distribution of the Securities may be deemed to be
&#147;underwriters&#148; within the meaning of the Securities Act. As a result, any profits on the sale of the Securities by such underwriters, dealers or agents and any discounts, commissions or agent&#146;s commissions or concessions received by
any such underwriter, dealer or agent who are deemed to be underwriters will be deemed to be underwriting discounts and commissions under the Securities Act. The specific terms of any <FONT STYLE="white-space:nowrap">lock-up</FONT> provisions in
respect of any given offering will be described in the applicable Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Prospectus Supplement relating to each
distribution of Securities will also set forth the terms of the offering of the Securities, including to the extent applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name or names of any underwriters, dealers, or agents and the respective amounts underwritten;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether any underwriter, dealer, or agent has a material relationship with the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initial offering price, the proceeds to the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the underwriters&#146;, dealers&#146; or agents&#146; compensation or other discount or selling concession to be
allowed or <FONT STYLE="white-space:nowrap">re-allowed</FONT> to underwriters&#146; or dealers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the nature of the obligation of the underwriters; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the underwriter, dealer or agent has any arrangement with the Company, such as an over-allotment option.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with any offering of Securities, other than an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> distribution&#148;, the underwriters may over-allot or effect transactions which stabilize, maintain or otherwise affect the market price of the
Securities at a level other than those which otherwise might prevail on the open market. Such transactions may be commenced, interrupted or discontinued at any time. No underwriter, dealer or agent involved in an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> distribution&#148; of any of the Securities under a Prospectus Supplement, and no affiliate of any such underwriter, dealer or agent, and no person acting jointly or in concert with any
such underwriter, dealer or agent, will over-allot any Securities in connection with their distribution or effect any other transaction that is intended to stabilize or maintain the market price of the Securities being distributed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers and agents who participate in the distribution of the Securities may be entitled under agreements to be entered into
with the Company to indemnification by the Company against certain liabilities, including liabilities under the Securities Act, or to contribution with respect to payments that such underwriters, dealers or agents may be required to make in respect
thereof. In compliance with the guidelines of the Financial Industry Regulatory Authority, Inc. (&#147;<B>FINRA</B>&#148;), the maximum consideration or discount to be received by any FINRA member or independent broker dealer may not exceed 8% of
the aggregate proceeds of the offering. Such underwriters, dealers and agents may be customers of, engage in transactions with, or perform services for us in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each distribution of Securities (other than Common Shares) will be a new issue of securities with no established trading market. Unless
otherwise specified in a Prospectus Supplement relating to a series of Securities, the Securities (other than Common Shares) will not be listed on any securities exchange. Certain broker dealers may make a market in the Securities, but will not be
obligated to do so and may discontinue any market making at any time without notice. No assurance can be given that any broker dealer will make a market in the Securities of any series or as to the liquidity of the trading market, if any, for the
Securities of any series. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_15"></A>MATERIAL INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable Prospectus Supplement may describe the material U.S. federal income tax consequences of the acquisition, ownership and
disposition of any of the Securities offered by this Prospectus to an investor who is subject to U.S. federal income tax. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable
Prospectus Supplement may also describe material Canadian federal income tax considerations generally applicable to investors described therein of purchasing, holding and disposing of the applicable Securities, including, in the case of an investor
who is not a resident of Canada, Canadian <FONT STYLE="white-space:nowrap">non-resident</FONT> withholding tax considerations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_16"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in a Prospectus Supplement, certain legal matters relating to the offering of the Securities will be passed upon on
behalf of the Company by Torys LLP, New York, New York and Toronto, Canada. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_17"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of the Company and Pure Sunfarms Corp. incorporated in this Prospectus by reference to the Annual Report on Form 10-K
of the Company for the year ended December 31, 2019 have been so incorporated in reliance on the reports of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and
accounting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_18"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the information requirements of the Exchange Act and, accordingly, we file reports with and furnish other information to the
SEC. We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act with respect to the Securities offered by this Prospectus. This Prospectus does not contain all of the information
contained in the registration statement that we filed. For further information regarding us and the Securities covered by this Prospectus, you may desire to review the full registration statement, including its exhibits. The SEC maintains an
Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including the registration statement and its exhibits. The SEC&#146;s website address is
http://www.sec.gov. We maintain a website at www.villagefarms.com. Information contained in or accessible through our website does not constitute a part of this Prospectus. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom88408_19"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information we file with the SEC. This means that we can disclose important
information to you by referring you to those documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate by reference into this Prospectus the documents listed below: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520094235/d853826d10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2019, filed with the SEC on April&nbsp;1, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520009121/d874840d8k.htm">January&nbsp;17,
 2020</A> (Item 8.01 only); <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520061806/d895071d8k.htm">March&nbsp;4, 2020</A> (Item&nbsp;
1.01 only); <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520071693/d859325d8k.htm">March&nbsp;12, 2020</A> (Item&nbsp;
8.01 only); <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520079239/d898470d8k.htm">March&nbsp;19, 2020</A> (Items&nbsp;
1.01 and 8.01 only); <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520083448/d823899d8k.htm">March&nbsp;
24, 2020</A> (Item 8.01 only); <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520091128/d910378d8k.htm">March&nbsp;30, 2020</A> (Item&nbsp;
8.01 only) and <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520115018/d918314d8k.htm">April&nbsp;22, 2020</A> (Item&nbsp;5.02 only); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the description of our common shares set forth under the heading &#147;Capital Structure&#148; contained in our
Annual Information Form dated April&nbsp;
2, 2018, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312519012906/d647924dex9910.htm">Exhibit 99.10</A> to our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312519012906/d647924d40fr12b.htm">Form
 40FR12B</A> filed on January&nbsp;
18, 2019, as updated by <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520094235/d853826dex42.htm">Exhibit 4.2</A> to our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1584549/000119312520094235/d853826d10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2019, filed with the SEC on April&nbsp;1, 2020, including any amendment thereto filed for the purpose of amending such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, all documents filed by us under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, after the date of this Prospectus but
before the termination of the offering of the Securities covered by this Prospectus, are hereby incorporated by reference into this Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not authorized anyone to provide you with any different or additional information other than that contained in or incorporated by
reference into this Prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any information that others may provide. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement contained in a document incorporated or deemed to be incorporated by reference
into this Prospectus will be deemed to be modified or superseded for purposes of this Prospectus to the extent that a statement contained in this Prospectus or any other subsequently filed document that is deemed to be incorporated by reference into
this Prospectus modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The documents incorporated by reference into this Prospectus are available from us upon request. We will provide a copy of any and all of the
information that is incorporated by reference into this Prospectus but not delivered with the Prospectus to any person, including a beneficial owner, to whom a Prospectus is delivered, without charge, upon written or oral request. If exhibits to the
documents incorporated by reference into this Prospectus are not themselves specifically incorporated by reference in this Prospectus, then the exhibits will not be provided. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Requests for any of these documents should be directed to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Village Farms International, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4700-80th Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Delta, British
Columbia, Canada </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V4K 3N3 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(604) <FONT STYLE="white-space:nowrap">940-6012</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>10,887,097 Common Shares </B></P>
<P STYLE="font-size:70pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g88408g01a88.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:80pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:80pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I><FONT STYLE="white-space:nowrap">Co-Lead</FONT> Placement Agents </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:15pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:15pt">
<TD VALIGN="top" ALIGN="center"><B>A.G.P.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Raymond James</B></TD></TR>
</TABLE> <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I><FONT STYLE="white-space:nowrap">Co-Placement</FONT> Agent </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Roth Capital Partners </B></P>
<P STYLE="margin-top:70pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>January&nbsp;15, 2021 </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g88408g01a88.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g88408g01a88.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1?R4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %]:^80(X0DE-! 0      %X< 5H  QLE1QP"   " ?D< E  "')R,CDS
M.3DX' (% #U-:6-R;W-O9G0@5V]R9" M(#@X-# X(%9I;&QA9V4@1F%R;7,@
M("T@4')O<W!E8W1U<R!3=7!P;&5M96YT.$))300E       0'8Z1K)D+W/CJ
M9F-O5!" <SA"24T$.@      Y0   !     !       +<')I;G1/=71P=70
M   %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT
M   /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M 0      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %,
M90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U
M:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M     !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#
M;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O
M;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;
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M=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M    #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N
M9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P
M;&]N9P      .$))30/M       0 [_^-0 "  (#O_XU  (  CA"24T$)@
M    #@             _@   .$))300-       $    >#A"24T$&0
M!    !XX0DE- _,       D           $ .$))32<0       *  $
M     CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H
M!@       0 R     0!:    !@       0 U     0 M    !@       3A"
M24T#^       <   _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@     _____________________________P/H   X0DE-! @      !
M   !   "0    D      .$))300>       $     #A"24T$&@     #-0
M  8              -4   &#          $
M 0             !@P   -4                      0
M           0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M      !"=&]M;&]N9P   -4     4F=H=&QO;F<   &#    !G-L:6-E<U9L
M3',    !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M        !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC
M94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC
M951Y<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<
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M=&QO;F<      #A"24T$*       #     (_\        #A"24T$$0
M 0$ .$))3004       $     CA"24T$#      -60    $   "@    6
M >   *4    -/0 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2
M ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.
M#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M_\  $0@ 6 "@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!
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MU.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\
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M?%13M^DWXC\J*G__T-1)))8C337X63155?:T"NX2P@SY^Y!6S@D]0Z,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$!_\  $0@ DP$+ P$1  (1 0,1 ?_$ !X   $#!0$!
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MQ(!>X#>)(]48?V$^ UBC>I*B$IN%7*>.+< VXX/3BX/L&%R92YTY$A*5%2E
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MC?3\6[Z&_!Z5C-K+>8=2J])I;4@=^F@PX_B4AQ&T>F/LU-"5/HOXE)2E)()
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M30G#+4\$E2W'B75NWL-VZ]C<$D8V9E1T/QE J9A0J8.TK-.2!VNUHM92"YV
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M(G,H@%BY21<L '9]K1;*GHY0UEY,U<H$E:B%E3DN&%R +\3ML;WU#[#W9PR
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M2\_9JEP+!(8D5N>=J=H20$I<CFWE?W\*XQ/+Z:=)%2Q(F5LWJ$@A(ZTN18<
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MHTT=I@LG5@ +$AK@<!8MYL8Y+-:+<B4VV6S&1)<3'[I7 ;191)%U7\1(!O\
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M.U3G4WXWJ+U,53J*44LS7S#4\(D6Z@A*DI2]WA[RYXL195^!9>G&(SEUM-3
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M:K5=5#J4%^0XNFNQ%/K0889+ECL!%B$;2!8D@'&S0=(36](3)(="I@!!<AB
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M)QY]7?V'VQGT&L=C2+)XAV\F ]G.$%&J1Z4ZH*^BGU _DVG\_J]F3T8QT_\
M03CWR_\ 0PZ*&O'_ $BA_ ![ J*A0JL>12ZC;V^@ST_@6R?QYQC^3&/[4$T
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M*QL#0Z8GWJCH/0'CEOW'[#A<O"</=U2):@QL18^9.SPDHEM_PTG3Y'EN>6T
MRCE0 GXDI1 Y4?0TFU_,E.T#RZCV&_.'?V1AOU23?3LI\A:$=5+^C [TM[8]
M#D_*9%A1:8DWM?T=D\VO:VP\GR'7D8;.%X:0W4R>X(3X#0QGJD;H&CW&O"QU
M_7?&FYA>TVRS)H46JP*>R[F"?\54T*BQTI>EN)ND!2RT5I3P$A.ZZU@7N0,(
M.'87+(!DR!F/9&5-]M"07\]MM$J$I*DA4N7?@E-V%] QYL27.D;<WE3*I"5B
M@TPI/][T5 !OQ_[,@'VB]QR"<+3A>'$OZ/+(.KH#7XWMY6AP(EL0$)TL62UN
M%@SC3?:/;U0RGU^)J9R!P&6N.O!N@=2>,.?LC#1K2R6.CI2WA;>,=4@_\M!X
M]@'\(\3E'*AO:C4RQ-MW<,V!)MU+?7[>F$JP?#5!DTTD%CHD?A>#JY;?\)'?
ME&UNZT5>IN6FKJ^):?:W7T=JP%^I_P!"D6Z>?Y\(1@E "<U/+4&MV4^[]>4*
M")8#B7+<EFR#U:[^?"T4^J^5K[/B2F'<;7]':*B?/D 7(Z<"XMTXPY^R,, 8
MTT@$NSI2_+75HP4)-^K2UODAK>$+ZIY8M<4:GVL#<L(4-IO8\(/4@V/3@B^$
MG"L.3K(EC=BAG\^;<HR$(/\ RT>(;UO[^Z%]5,L$FU(II((!VQ4'D]. WQT]
MQY]^,(P_#5+_ ':00P89+/WMXZVWC&1!=I:..@L!KKJ?=I%C4:)E"F1E/3*5
M3&@TVIQQ7H[2 $)%RM16@#: +DW'GSP;-5%!ATLDBGE)8%V2![!M?O8\82L2
MD)*E(3E&I*1H2VE[@^=K<6SU3M!Z%4ZHS8K41=6CTQX,U&J4FAHJ5&@JN M,
MR?$WLQPV%)6I;BTH"2#O-SB*F+H$%A3H4 -D D[:;W',O;C&MU]'?L7'_:D<
M= U]^(\A';\INZ;YSIL:N9=:H=5I4I!4W*B,,.I*@HI("V XFZE#D%5[$CSX
ME*>BH)Z4'T>6$K2"Q0!JEVX>%^X!H>$JG("A+%V4.R;V!?0-KL[^#G;T94RP
MNY^)*01<@=Y%1?CK:[9)'M]G0XV_V3AXUII)_A2&Y']#CI"NHE%OYI)/]D'?
M:WZ,7(R?E,@'XEI._BX3$0;*\P!W:>0?*XY\\!PG#B#_ $:3<?-'ZW'G ),D
M,>IE\CEW\VBE64\KI( I%,NJ]AZ*A)-C;BP63S<>5C<<^31P?#;?S$@;70+^
ML0KJY>O52_\ Q\?9%7JAE?:5&C4\VZCT-&TGV$]UY^?B'TC"3@N&#M&1*X_%
M%VV%WY:P=5+UZN6/!(;VGV\H\_5'*J]P-!IHV6W 1FP1?INN%6XZ7 Q@87A*
MB0::42.* &Y;ZV/A&3+1NA"N].GJ&OX12<FY5/(HL!(%@=K#(%STO_HSR?QP
MK]BX8JZ:621_9;V"_?"#)E$N9:/_ !$5^JV51X!1:85#C:(20LVXZJL+\<GB
M]C87XQG]CX9IZ/).WQ WN_"%B3+^B26&G9?Q#/'H,I4$ ;<NT^Q\Q#8-_>=P
M7S]8QD870H<2J60QN?YH&_B#MW1@2I9=T2['0AO)M?,Z1<>J5!"+_$%-OM''
MH;.[I[-H%QYC@87Z!3@6II-AIU"/)\L'4RG^*E^:1E\W-N!:/+U5H?\ [OP/
M^ 8QCT&3]5D_8R_RQGJ9?S97DGW1>-99HR6TI31X* +V2(C  N23QL-KDWZ^
M>'4T4@) ]'E#6W5H&YVC'5RQ;(CP<#U$#U1M.-^%08((,$$&""-%SS47J/EZ
MJ5",@KD1H[\AL D$K25[ ".001>XO_A%XA.]&EE8#DYM#Q;_ '(][QD"Q/!O
M%S#+.SA1Z+_1N]JQF&&S5\SU^'+K]=K+<9N=5)"(RI+;,-M2@M0+3#"60VV$
MD+!/0G%<H)<NJ7.FSDYBD@@%BSE0-[@YLOLY1JRTI5F4I+L7#L;7=N!/JLQB
M_P H:SZ053/OH]*RQ+R[G"LP9++<Z;EQZD3*E%@.G<A<E49#3C6X;AO)*@;K
M.TWP_-K:>F)"$Y57#V !V%N+]W'A""N2E1 00JX!#!CY*9]'9N8+QA\I:_ZH
MYLK5;FQ<M4:CY(RA6ZK3*Q7Y=10Z]/B11="H80DK0M&TA6U.P*X"MW725CJT
M!QF(2.T;,Q[RYY,_#0P@3YN0S/DBY=G:^GR6TT+OZO:-KUK+,I[V=H.6,OG)
MK $U,,UDJK$F@(&_XP2LJ"D2%!6X1THW6M?V%R3CBYH< CFXV(!L[Z@W\6:X
M;17+4@+R$I<VS(>Q;1WO:_ 'B&SN9>TC5)+&6*?D.GQJO6LWTPU-A<^4EN-3
MHC3;3KCTLK2$NDE?<IW$JW75\GJW-Z1RY1RY\RCJVH?6^EV(YW#G=2ZXL E)
M<EA<!M]^[>Q!\!D,F:X9S55JGE#/5,IL#,,.CN5NFNTF<F1!J<,*2W=2$)VM
MJ:=?:;4FQN$DIOQ;*.D*E=D N =P1Y.QUTOS:%(J%G,@CM .%.+[!\KCO'$:
M7,<YH?:$U^S=3*EF?*^GV7'Z;0JU5::\W.K3;<NK1Z7M#CL9"&TN;EAS>$I5
M?:VH+N+X=1BLZ8"4@IUV#Z/L7U(X.6XM&VB9F25Y=+,2"YW'@\6VJ^J\K-N5
M=(\\Y<I/IT^1G"$F'37%A*A.6M#2XX6$%:6F'6' 3\H)2%$D<XB*_%ZCK)12
M%GM*! .A!! Y@Z<-!LT:<^?GZLH204J4"+/H#H"&.P)+ZZZ1T"BZR:J97S50
M:+J9EZC1:+FUY$.C5*B5%R3Z)/6I9$2>V4BVQ#1\:DD7"03<WQ))Q>?(]'ZY
M*CU[EW 2G9SJ]^-M@;0\BH6E00M.K"V4MKJW#1MWO9X1_6;6#.=4JPTORWE^
M3EVASUTYRIU^J^AN5.6$H2Y'C(>0+,LN%8+C8VJ6WM) VG$A*Q%<[XBDD,X<
MFPV&UMQM?9X=$X$V2;'CL^^AT;3U&+M/:1J1R=2JZU0VHU;5FB!EC,5(GO*5
M\63U.,MN;%I2$JVN+/=J!V+ "NA%M6=CAIUA"B2K,Q LSZ \W<>/$/"?2020
MQ<**2YW=K<E/?F/+LN?]2ZEE=G)R8<"/(]9ZM"I;UWBC8)$<OJ(V[A<E*MHM
M8#VVL):?BHD4DN<7.=@ "Q<A[D_H&^]WE.6((#D?&WY6%R>(WWC@SNL.K^8\
MSUV%DK+F6UQ<M3?07HE7JB8M2J*R$+,J&2WWK<=!46RM'!4@FX/.()&,S:F:
MZ5&6$$$I4Q<.3RX-RTM"#G)++2_ ZGS+^UN,;%GW6G.E"7E;+.7\M4^9G;,$
M9R1+ITBI=U2Z.Q';:5)E.32V4R$B1(9;'C*SO-@0,.5F-JS)0A3+9B7<,19G
M.YNS^5V8F3UH8 !SP];O8,6U,972S5S-\[.;N2-1J12J767H?QC29-(FIEQ:
MJP%M-J0E*$)*"TIQ-RLIO;KSC9PBN7/GF3,+ELV>S,;I!N38;@MKR=R14F:K
M(H,H;EB&-MK=^OMB[[5M;FP,BQZ;3Y2X3N8\P46BR);:]BFX,ZHQFY*"YP$I
M>96MI1*DWN0;#&[C<Q4F6&5=:@!Q8OKY#B6\X547EY"[*-[VL^EV;\=[1CYA
MT[TER%#[[+B95,2U&@.P:?1Q*DSGGFK*<D-ML.%95W:R5*N%; H7N#AJ3)D)
MIDSIB1,[+D#4V=B]G3Y=T:YERTBZ!S< DDEW?6W,\>,<ZI>NN0:=IQG?,&E6
M7#3$Y8==>F49VFRJ&EV:-CBBM+["&VW'5.*5O'@-[@74!C37BZ2%(ITJEJ3E
M2Q[V<,P/<^Y\4^D* (2E@"$B^PM8W :Y M:$C:_:C4S*K.:\X9=I$!6954Z%
MDNA0ZFW-F2ZE4$MN,"5(0C>VVILE2[\H'-^#AJ7BU2@D3%9@M0"6LPW<.^A
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G $I&@ >"/5E""DDI3\H] !Y#V6^W"H(N.F""#!!!@@@P008((__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g88408g37c77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g88408g37c77.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1IZ4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &EZ^9U X0DE-! 0       \< 5H  QLE1QP"   " ?\ .$))300E
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M;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
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M;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M  !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M     !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL
M;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I
M9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M ! #O_XU  (  @.__C4  @ ".$))300F       .             #^    X
M0DE-! T       0    >.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         ".$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      ,U    !@              A@   .\
M         0                         !              #O    A@
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    A@
M  !29VAT;&]N9P   .\    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3001       ! 0 X0DE-!!0       0    #
M.$))300,      _J     0   *    !:   !X   J,    _. !@  ?_8_^T
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M/]7,JUL
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M  (1 0,1 ?_$ !X   (!! ,!               !!P(&" D$!0H#_\0 8A
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MY;2@&M X#L=]CLVIW+(D,-2_73?=NH 8VLY&_"@%SH&X:[:A^!)<5JP.UBS
M Z7-M=MP?B2+"^EF(0DGC05TWV(\ #4TUJX)8LP(8':S@7O]=@VI(;8@JY!<
MC>K$TIZJE] "^X)8#.0[:AK=6WU)/3H =+A=@6?0O7@^V@ X\21K0L/H;/JP
M=M?B=;N S@7L.!JD5;1RSZ> THQ+L32IL61+C;38LY/=?XA[OUL% 8[Z[AV
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M,SI4 X026"E!]"]2%DL06K;OJ.H6L,PIM]S]$R"8U!./1/3?1)60 0"P<E0
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MPHH!)4&9*LJBH=DM4&UA=L/.FE<[,UL*I*/P(CU5 2I4JA9I%PGJ_P!-*R+
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MP'#W*W)>\ZOR23NB+%B5.5*#F+D:BK/IR)9VMO25V3L\1Y&B+$6Q*4H1UA/
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M<_/%XIT8EP'<.:.=<U05  ,2[Q*\IJ8FYI2E@%86'2OM!0'G5J74:ER?&I/
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M"^H<$/MXDO8#@''8/1S30L06W[@&J38LR]M78$ZD:GP+_"S!B&?A U=&<@:
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M9W.B5!GYDX:""26',UB#QAZ2;YO25Q==7DBR$I1"6APJBEH2HH;0!14Q5J
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M/802:;U#(H29B8+E88SE,B.#AX:I&$+8I!*P5)2I2/=!#E,=(L\%19N2N6%
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MEBQ<_P"KL0>Y_$@$:_$/P4'WVX(YMW D'3P+6+!U-]+@AB6L19] YO\ !]N
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M#]U11^+1SJ[!^%D]HER\8_WR?R6X'LR<AA$B&-15I<<S^NU\[F^Q9[G30@V
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MCSJ+[]?JZ_T^?>]8._?3X?D5;T<!W4WG1@&V*!_E8]F#D?M4%9_[YBN_J_\
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MKFTJR_M'TXFGZXG-32"=T=-* BY9 U+3LT*9C,80SPA,@,IQ,+#/KU-3@H&
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MQG*%+5#R9",-2/.8F)B'#3B\IP4A2E88WYB_C+"[!,W7$$2,5!*0RU(4!E)
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M4--0,QDTUI2)BS+$5534Y*1RX<X5AJ&%/<+%P,/%P2HE#\R2>481Q-C$$A.
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M/YC."I\L$]GV,RQB(&-C)5+J.G5;(BI'AT4*6*!AXD\DB7"U%(PV12APT*0
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:%GP6+'!8L<%BQP6+'!8L<%BQP6+'!8M__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
